Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 1061 articles:
HTML format



Single Articles


    March 2024
  1. JAIRATH V, Hunter Gibble T, Potts Bleakman A, Chatterton K, et al
    Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2024 Mar 21:izae044. doi: 10.1093.
    PubMed     Abstract available


  2. JOLVING LR, Zegers FD, Lund K, Wod M, et al
    Children and Adolescents Diagnosed With Inflammatory Bowel Disease Are at Increased Risk of Developing Diseases With a Possible Autoimmune Pathogenesis.
    Inflamm Bowel Dis. 2024 Mar 20:izae047. doi: 10.1093.
    PubMed     Abstract available


  3. FIORINO G, Bent-Ennakhil N, Varriale P, Braegger F, et al
    Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.
    Inflamm Bowel Dis. 2024 Mar 20:izae015. doi: 10.1093.
    PubMed     Abstract available



  4. Correction to: Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
    Inflamm Bowel Dis. 2024 Mar 14:izae070. doi: 10.1093.
    PubMed    


  5. ALSOUD D, Van Calster B
    Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Mar 9:izae048. doi: 10.1093.
    PubMed    


  6. SANDS BE, D'Haens G, Clemow DB, Irving PM, et al
    Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
    Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093.
    PubMed     Abstract available


  7. FAMUTIMI D, Alayo QA, Deepak P
    Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Mar 8:izae049. doi: 10.1093.
    PubMed    


  8. PILLAY L, Subramanian S
    The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Mar 7:izae025. doi: 10.1093.
    PubMed    


  9. GEERTSEMA S, Fagundes RR, Otten AT, Dijkstra G, et al
    Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
    Inflamm Bowel Dis. 2024 Mar 5:izae042. doi: 10.1093.
    PubMed    


  10. HOXHA T, Youssef M, Huang V, Tandon P, et al
    Inflammatory Bowel Disease and Breastfeeding: A Narrative Review.
    Inflamm Bowel Dis. 2024 Mar 4:izae033. doi: 10.1093.
    PubMed     Abstract available


  11. OURANOS K, Saleem H, Vassilopoulos S, Vassilopoulos A, et al
    Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2024 Mar 1:izae031. doi: 10.1093.
    PubMed     Abstract available


  12. GREYWOODE R, Nahvi S, Ullman T, Keefer L, et al
    Feasibility and Acceptability of Digital Behavioral Interventions Among Black and Hispanic Patients With Inflammatory Bowel Disease: A Randomized Pilot Study.
    Inflamm Bowel Dis. 2024 Mar 1:izae034. doi: 10.1093.
    PubMed    


  13. D'AMICO F, Peyrin-Biroulet L, Danese S
    Disease Clearance is not Synonymous with Cure.
    Inflamm Bowel Dis. 2024;30:509.
    PubMed    


  14. HESAMPOUR F, Bernstein CN, Ghia JE
    Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches.
    Inflamm Bowel Dis. 2024;30:482-495.
    PubMed     Abstract available


  15. TSE CS, Hunt MG, Brown LA, Lewis JD, et al
    Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions.
    Inflamm Bowel Dis. 2024;30:501-507.
    PubMed     Abstract available


  16. GEESALA R, Zhang K, Lin YM, Johnson JC, et al
    Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating Mechanical Stress-Induced Th17-Polarizing Cytokines in Crohn's-like Colitis.
    Inflamm Bowel Dis. 2024;30:429-440.
    PubMed     Abstract available


    February 2024
  17. SWAMINATHAN A, Borichevsky GM, Frampton CM, Day AS, et al
    Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Feb 28:izae032. doi: 10.1093.
    PubMed     Abstract available


  18. GONG T, Brew BK, Lundholm C, Smew AI, et al
    Comorbidity Between Inflammatory Bowel Disease and Asthma and Allergic Diseases: A Genetically Informed Study.
    Inflamm Bowel Dis. 2024 Feb 27:izae027. doi: 10.1093.
    PubMed     Abstract available


  19. DALAL RS, Winter RW, Gupta S, Sasson GF, et al
    Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States.
    Inflamm Bowel Dis. 2024 Feb 26:izae038. doi: 10.1093.
    PubMed    


  20. QING X, Zhang C, Zhong Z, Zhang T, et al
    Causal Association Analysis of Periodontitis and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization Study.
    Inflamm Bowel Dis. 2024 Feb 26:izad188. doi: 10.1093.
    PubMed     Abstract available


  21. MARTINELLI M, Miele E, Staiano A
    Surgical Complications Need to Be Carefully Excluded Before Ruling Out a Diagnosis of De Novo Crohn's Disease.
    Inflamm Bowel Dis. 2024 Feb 24:izae026. doi: 10.1093.
    PubMed    


  22. DE JONG D, Reijntjes M, Buskens C, Hompes R, et al
    Response to "De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN".
    Inflamm Bowel Dis. 2024 Feb 22:izae021. doi: 10.1093.
    PubMed    


  23. GREEN Z, Ashton JJ, Rodrigues A, Spray C, et al
    Sustained Increase in Pediatric Inflammatory Bowel Disease Incidence Across the South West United Kingdom Over the Last 10 Years.
    Inflamm Bowel Dis. 2024 Feb 19:izad302. doi: 10.1093.
    PubMed     Abstract available


  24. FAN X, Liu Y, He Z, Bai Y, et al
    Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
    Inflamm Bowel Dis. 2024 Feb 16:izae019. doi: 10.1093.
    PubMed    


  25. KUENZIG ME, Bitton A, Carroll MW, Otley AR, et al
    Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study.
    Inflamm Bowel Dis. 2024 Feb 16:izae010. doi: 10.1093.
    PubMed     Abstract available


  26. URRETE J, Mitra T, Boland BS, Bertrand K, et al
    Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Feb 9:izae023. doi: 10.1093.
    PubMed    


  27. ATIA O, Lujan R, Buchuk R, Greenfeld S, et al
    Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRN.
    Inflamm Bowel Dis. 2024 Feb 8:izae014. doi: 10.1093.
    PubMed     Abstract available


  28. PRENTICE R, Flanagan E, Wright E, Hardikar W, et al
    Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero.
    Inflamm Bowel Dis. 2024 Feb 8:izae008. doi: 10.1093.
    PubMed     Abstract available


  29. SUTTICHAIMONGKOL T, Coelho-Prabhu N, Bruining DH, Tariq R, et al
    Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center.
    Inflamm Bowel Dis. 2024 Feb 3:izae005. doi: 10.1093.
    PubMed     Abstract available


  30. WANG C, Yang F, Qiao L, Wang X, et al
    Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study.
    Inflamm Bowel Dis. 2024 Feb 3:izae006. doi: 10.1093.
    PubMed     Abstract available


  31. SKEJO C, Thim S, Sellmer A, Julsgaard M, et al
    Early Onset Sepsis and Lobar Pneumonia in a Newborn Exposed In Utero to Ustekinumab and Azathioprine.
    Inflamm Bowel Dis. 2024;30:314-315.
    PubMed    


  32. SHI Y, Ullah S, Liu BR
    Think Again Before Resecting an Organ: Appendectomy or Endoscopic Retrograde Appendicitis Therapy?
    Inflamm Bowel Dis. 2024;30:320-321.
    PubMed    


  33. WANG Z, Dreesen E
    Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle.
    Inflamm Bowel Dis. 2024;30:316-317.
    PubMed    


  34. VESTERGAARD T, Rosok J, Julsgaard M, Bek Helmig R, et al
    Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD.
    Inflamm Bowel Dis. 2024;30:222-229.
    PubMed     Abstract available


  35. POWERS JC, Cohen BL, Rieder F, Click BH, et al
    Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases.
    Inflamm Bowel Dis. 2024;30:203-212.
    PubMed     Abstract available


  36. DARLINGTON K, Wang A, Herfarth HH, Barnes EL, et al
    The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2024;30:196-202.
    PubMed     Abstract available


    January 2024
  37. BRIGGS K, Tomar V, Ollberding N, Haberman Y, et al
    Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism.
    Inflamm Bowel Dis. 2024 Jan 30:izae003. doi: 10.1093.
    PubMed     Abstract available


  38. ZAMANI M, Ebrahimtabar F, Alizadeh-Tabari S, Kasner SE, et al
    Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2024 Jan 25:izae012. doi: 10.1093.
    PubMed     Abstract available


  39. D'HAENS G, Higgins PDR, Peyrin-Biroulet L, Sands BE, et al
    Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
    Inflamm Bowel Dis. 2024 Jan 25:izae004. doi: 10.1093.
    PubMed     Abstract available


  40. NAMBU R, Miyazawa A, Yoshida M, Hara T, et al
    Long-term Efficacy and Safety of Tacrolimus Plus Ustekinumab Combination Therapy in Children With Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Jan 24:izae013. doi: 10.1093.
    PubMed    


  41. DUBINSKY MC, Charles L, Selmaj KW, Comi G, et al
    Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.
    Inflamm Bowel Dis. 2024 Jan 24:izae011. doi: 10.1093.
    PubMed    


  42. KRASNOVSKY L, Weber AT, Gershuni V, Pettke E, et al
    Preoperative Exclusive Enteral Nutrition Is Associated With Reduced Skin and Soft Tissue and Intra-abdominal Infections in Patients With Crohn's Disease Undergoing Intestinal Surgery: Results from a Meta-Analysis.
    Inflamm Bowel Dis. 2024 Jan 23:izad304. doi: 10.1093.
    PubMed     Abstract available


  43. KATSOUDAS N, Tavakoli P, Wu N, Shapiro A, et al
    Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?
    Inflamm Bowel Dis. 2024 Jan 19:izad318. doi: 10.1093.
    PubMed     Abstract available


  44. ALAYO QA, Famutimi D, Ayoub M, De Las Fuentes L, et al
    Performance of ASCVD Risk Prediction Models in Individuals With Inflammatory Bowel Disease: A UK Biobank Study.
    Inflamm Bowel Dis. 2024 Jan 18:izae007. doi: 10.1093.
    PubMed    


  45. ALSOUD D, Sabino J, Franchimont D, Cremer A, et al
    Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
    Inflamm Bowel Dis. 2024 Jan 12:izad315. doi: 10.1093.
    PubMed     Abstract available


  46. WATSON A, Karam LB, Kellermayer R
    Failure Rate of Anti-Tumor Necrosis Factor alpha Biologics in Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Jan 11:izad313. doi: 10.1093.
    PubMed    


  47. FRETZ KM, Hunker KE, Tripp DA
    The Impact of Inflammatory Bowel Disease on Intimacy: A Multimethod Examination of Patients' Sexual Lives and Associated Healthcare Experiences.
    Inflamm Bowel Dis. 2024 Jan 11:izad106. doi: 10.1093.
    PubMed     Abstract available


  48. COLLEN LV, Snapper SB
    Response to Letter to the Editor: "Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2024 Jan 11:izad317. doi: 10.1093.
    PubMed    


  49. LIU M, Zhang Y, Liu J, Xiang C, et al
    Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Jan 11:izad187. doi: 10.1093.
    PubMed     Abstract available


  50. ATIA O, Friss C, Focht G, Magen Rimon R, et al
    Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
    Inflamm Bowel Dis. 2024 Jan 8:izad301. doi: 10.1093.
    PubMed     Abstract available


  51. ERFAN R, Shaker OG, Khalil MAF, Mahmoud FAM, et al
    Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Jan 8:izad210. doi: 10.1093.
    PubMed     Abstract available


  52. KHADEMI Z, Pourreza S, Amjadifar A, Torkizadeh M, et al
    Dietary Patterns and Risk of Inflammatory Bowel Disease: A Systematic Review of Observational Studies.
    Inflamm Bowel Dis. 2024 Jan 5:izad297. doi: 10.1093.
    PubMed     Abstract available


  53. ALVISI P, Faraci S, Scarallo L, Congiu M, et al
    Major Abdominal Surgery for Pediatric Crohn's Disease in the Anti-TNF Era: 10-Year Analysis of Data From the IBD Registry of Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition.
    Inflamm Bowel Dis. 2024 Jan 5:izad310. doi: 10.1093.
    PubMed     Abstract available


  54. BLESL A, Wurm P, Waschina S, Grochenig HP, et al
    Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter Study.
    Inflamm Bowel Dis. 2024;30:9-19.
    PubMed     Abstract available


  55. FU SC, Qu JY, Li LX, Yang XX, et al
    Excessive Mitochondrial Fission Suppresses Mucosal Repair by Impairing Butyrate Metabolism in Colonocytes.
    Inflamm Bowel Dis. 2024;30:114-124.
    PubMed     Abstract available


  56. TUBAU-JUNI N, Bassaganya-Riera J, Leber AJ, Alva SS, et al
    Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Inflamm Bowel Dis. 2024;30:103-113.
    PubMed     Abstract available


  57. ODUFALU FD, Sewell JL, Rudrapatna V, Somsouk M, et al
    Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.
    Inflamm Bowel Dis. 2024;30:29-37.
    PubMed     Abstract available


  58. GOLDOWSKY A, Singh R, Moss A
    Speaker Diversity and Audience Ratings at a National Inflammatory Bowel Diseases Conference.
    Inflamm Bowel Dis. 2024;30:78-82.
    PubMed     Abstract available


  59. LEDDER O, Harel S, Lujan R, Friss C, et al
    Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
    Inflamm Bowel Dis. 2024;30:1-8.
    PubMed     Abstract available


  60. FAYE AS, Lee KE, Hudesman D, Dervieux T, et al
    Older Adults With Inflammatory Bowel Disease Are at Higher Risk of Developing Antibodies to Infliximab.
    Inflamm Bowel Dis. 2024 Jan 3:izad305. doi: 10.1093.
    PubMed    


  61. COLMAN RJ, Vuijk SA, Mathot RAA, Van Limbergen J, et al
    Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar Pharmacokinetics.
    Inflamm Bowel Dis. 2024 Jan 3:izad307. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  62. FORBES AJ, Frampton CMA, Day AS, Kaplan GG, et al
    The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence.
    Inflamm Bowel Dis. 2023 Dec 30:izad295. doi: 10.1093.
    PubMed     Abstract available


  63. TEWS HC, Schmelter F, Kandulski A, Buchler C, et al
    Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn's Disease and Ulcerative Colitis Compared With Healthy Control Individuals.
    Inflamm Bowel Dis. 2023 Dec 29:izad298. doi: 10.1093.
    PubMed     Abstract available


  64. DUBINSKY M, Rice A, Yarlas A, Hur P, et al
    Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
    Inflamm Bowel Dis. 2023 Dec 27:izad282. doi: 10.1093.
    PubMed     Abstract available


  65. FANSIWALA K, Rusher A, Shore B, Herfarth HH, et al
    Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease.
    Inflamm Bowel Dis. 2023 Dec 27:izad299. doi: 10.1093.
    PubMed     Abstract available


  66. ANIRVAN P, Giri S
    Tofacitinib in Ulcerative Colitis: Beyond Biologics?
    Inflamm Bowel Dis. 2023 Dec 24:izad308. doi: 10.1093.
    PubMed    


  67. DALAL RS, Allegretti JR
    Reply: Tofacitinib in Ulcerative Colitis: Beyond Biologics?
    Inflamm Bowel Dis. 2023 Dec 24:izad309. doi: 10.1093.
    PubMed    


  68. DUNLEAVY KA, Santiago P, Forde G, Harmsen WS, et al
    Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2023 Dec 23:izad278. doi: 10.1093.
    PubMed     Abstract available


  69. LEVINE J, McKibbin J, Ham R, Cohen-Mekelburg S, et al
    Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series.
    Inflamm Bowel Dis. 2023 Dec 23:izad279. doi: 10.1093.
    PubMed    


  70. VUYYURU SK, Ma C, Sharma T, Nguyen TM, et al
    Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Dec 22:izad293. doi: 10.1093.
    PubMed     Abstract available


  71. SPENCER EA, Bergstein S, Dolinger M, Pittman N, et al
    Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Dec 22:izad300. doi: 10.1093.
    PubMed     Abstract available


  72. SWAMINATHAN A, Fulforth JM, Frampton CM, Borichevsky GM, et al
    The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
    Inflamm Bowel Dis. 2023 Dec 22:izad294. doi: 10.1093.
    PubMed     Abstract available


  73. BRADY RE, Salwen-Deremer JK, Tunnell NC, Winter MW, et al
    Understanding Medication Nonadherence in Crohn's Disease Patients: A Qualitative Evaluation.
    Inflamm Bowel Dis. 2023 Dec 22:izad296. doi: 10.1093.
    PubMed     Abstract available


  74. CATALAN-SERRA I, Thorsvik S, Beisvag V, Bruland T, et al
    Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
    Inflamm Bowel Dis. 2023 Dec 16:izad289. doi: 10.1093.
    PubMed     Abstract available


  75. ALIZADEH M, Motwani K, Siaton BC, Abutaleb A, et al
    Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD.
    Inflamm Bowel Dis. 2023 Dec 15:izad280. doi: 10.1093.
    PubMed     Abstract available


  76. TAO S, Long X, Gong P, Yu X, et al
    Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies New Therapeutic Kinase Targets of Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Dec 12:izad291. doi: 10.1093.
    PubMed     Abstract available



  77. Correction to: Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.
    Inflamm Bowel Dis. 2023;29:2014-2015.
    PubMed    



  78. Inflammatory Bowel Diseases Is Moving to Online Only Publication.
    Inflamm Bowel Dis. 2023;29:2006.
    PubMed    


  79. BARNES EL, Kayal M, Schwartzberg DM
    The Rational Use of Advanced Therapies for Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2023;29:2007-2009.
    PubMed    


  80. CHEN X, Zhang M, Zhou F, Gu Z, et al
    SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis.
    Inflamm Bowel Dis. 2023;29:1929-1940.
    PubMed     Abstract available


  81. PELLINO G, Garcia-Granero A
    3D Imaging and Printing in Inflammatory Bowel Diseases: Limitations, Barriers, and Opportunities Toward "Haute Couture" Surgical Approaches.
    Inflamm Bowel Dis. 2023;29:1999-2000.
    PubMed    


  82. BARNES EL, Chang S
    Shedding New Light on High-Risk Phenotypes for Pouchitis.
    Inflamm Bowel Dis. 2023;29:2003-2005.
    PubMed    


  83. BAJZAT D, Keri AF, Imrei M, Koi T, et al
    Safety Analysis of Preoperative Anti-TNF-alpha Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2023;29:1971-1980.
    PubMed     Abstract available


    November 2023
  84. COLOMBEL JF, Martin-Arranz MD, Brinkman B, Guan M, et al
    HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn's Disease Patients.
    Inflamm Bowel Dis. 2023 Nov 29:izad273. doi: 10.1093.
    PubMed    


  85. DE VOOGD FA, Bots SJ, van Wassenaer EA, de Jong M, et al
    Early Intestinal Ultrasound Predicts Clinical and Endoscopic Treatment Response and Demonstrates Drug-Specific Kinetics in Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Nov 27:izad274. doi: 10.1093.
    PubMed     Abstract available


  86. GAO Y, Zhang B, Zhao D, Li S, et al
    Automatic Segmentation and Radiomics for Identification and Activity Assessment of CTE Lesions in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Nov 27:izad285. doi: 10.1093.
    PubMed     Abstract available


  87. TARIQ R, Dilmaghani S
    Machine Learning and Radiomics: Changing the Horizon of Crohn's Disease Assessment.
    Inflamm Bowel Dis. 2023 Nov 27:izad284. doi: 10.1093.
    PubMed    


  88. SAYAR S, Ozturk O
    A Case of Stricturing Crohn's Disease Treated With Multiple Session Balloon Dilatation and Self-Expandable Metal Stent.
    Inflamm Bowel Dis. 2023 Nov 24:izad287. doi: 10.1093.
    PubMed    


  89. YAN ANG Q, Plichta D, Kim S, Hyun-A Kim I, et al
    Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Nov 24:izad268. doi: 10.1093.
    PubMed     Abstract available


  90. DISTANTE M, Rotulo S, Ranalli M, Pedace E, et al
    Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2023 Nov 23:izad275. doi: 10.1093.
    PubMed     Abstract available


  91. ROSHANOV PS, Khanna R
    The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Nov 21:izad281. doi: 10.1093.
    PubMed    


  92. SHAW VR, Byun J, Pettit RW, Hou JK, et al
    An Atlas Characterizing the Shared Genetic Architecture of Inflammatory Bowel Disease with Clinical and Behavioral Traits.
    Inflamm Bowel Dis. 2023 Nov 20:izad269. doi: 10.1093.
    PubMed     Abstract available


  93. FERNANDES SR, Bernardo S, Saraiva S, Rita Goncalves A, et al
    Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched Analysis.
    Inflamm Bowel Dis. 2023 Nov 20:izad272. doi: 10.1093.
    PubMed     Abstract available


  94. SIGALL BONEH R, Westoby C, Oseran I, Sarbagili-Shabat C, et al
    The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.
    Inflamm Bowel Dis. 2023 Nov 18:izad255. doi: 10.1093.
    PubMed     Abstract available


  95. FIELD J, Fenton C, Zhang L, Brickman C, et al
    Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men.
    Inflamm Bowel Dis. 2023 Nov 10:izad266. doi: 10.1093.
    PubMed     Abstract available


  96. WONG SY, Colombel JF
    Cancer Screening in Patients With Inflammatory Bowel Disease: Don't Forget the Anus!
    Inflamm Bowel Dis. 2023 Nov 10:izad267. doi: 10.1093.
    PubMed    


  97. YAMADA S, Honzawa Y, Yamamoto S, Matsuura M, et al
    Single Nucleotide Polymorphisms of the MEFV Gene E148Q Are Highly Associated With Disease Phenotype in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Nov 10:izad259. doi: 10.1093.
    PubMed     Abstract available


  98. LITTLE RD, Swaine A, Reynolds R, Gibson DJ, et al
    Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
    Inflamm Bowel Dis. 2023 Nov 10:izad248. doi: 10.1093.
    PubMed     Abstract available


  99. CHEW DCH, Khoo XH, Lee TS, Chin KY, et al
    A Systematic Review on the Increasing Incidence of Inflammatory Bowel Disease in Southeast Asia: Looking Beyond the Urbanization Phenomenon.
    Inflamm Bowel Dis. 2023 Nov 3:izad189. doi: 10.1093.
    PubMed     Abstract available


  100. GONZALEZ CUETO E, Edmans M, Wellens J, Cadwell K, et al
    Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Nov 3:izad265. doi: 10.1093.
    PubMed    


  101. TUBAU-JUNI N, Hontecillas R, Leber AJ, Alva SS, et al
    Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2023 Nov 2:izad258. doi: 10.1093.
    PubMed     Abstract available


  102. RUBIN DT, Torres J, Dotan I, Xu LT, et al
    An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts.
    Inflamm Bowel Dis. 2023 Nov 2:izad247. doi: 10.1093.
    PubMed     Abstract available


  103. FEATHERS A, Lovasi GS, Grigoryan Z, Beem K, et al
    Crohn's Disease Mortality and Ambient Air Pollution in New York City.
    Inflamm Bowel Dis. 2023 Nov 2:izad243. doi: 10.1093.
    PubMed     Abstract available


  104. CHANG S, Hong S, Hudesman D, Remzi F, et al
    Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2023;29:1769-1777.
    PubMed     Abstract available


  105. LUO Y, Schmidt N, Dubinsky MC, Jaffin B, et al
    Evaluating lleal Pouch Anal Anastomosis Function: Time to Expand Our ARM-amentarium.
    Inflamm Bowel Dis. 2023;29:1819-1825.
    PubMed     Abstract available


  106. NARDONE OM, Calabrese G, Barberio B, Giglio MC, et al
    Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis.
    Inflamm Bowel Dis. 2023 Nov 1:izad252. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  107. KRUGLIAK CLEVELAND N, Ghosh S, Chastek B, Bancroft T, et al
    Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
    Inflamm Bowel Dis. 2023 Oct 31:izad245. doi: 10.1093.
    PubMed     Abstract available


  108. GUO A, Ostensson M, Stordal K, Ludvigsson J, et al
    Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 31:izad257. doi: 10.1093.
    PubMed     Abstract available


  109. RIGGOTT C, Fairbrass KM, Selinger CP, Gracie DJ, et al
    Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study.
    Inflamm Bowel Dis. 2023 Oct 31:izad256. doi: 10.1093.
    PubMed     Abstract available



  110. Correction to: Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2023 Oct 27:izad261. doi: 10.1093.
    PubMed    


  111. FU J, Chai C, Chen L, Cai M, et al
    Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 27:izad262. doi: 10.1093.
    PubMed     Abstract available


  112. HUANG Z, Cheng W, Chao K, Tang J, et al
    Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2023 Oct 27:izad251. doi: 10.1093.
    PubMed     Abstract available


  113. ASSADSANGABI A, Evans CA, Corfe BM, Lobo AJ, et al
    Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach.
    Inflamm Bowel Dis. 2023 Oct 27:izad241. doi: 10.1093.
    PubMed     Abstract available


  114. WELLENS J, Chen J, Fu T, Zhang Y, et al
    Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
    Inflamm Bowel Dis. 2023 Oct 25:izad249. doi: 10.1093.
    PubMed    


  115. SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
    Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2023 Oct 25:izad246. doi: 10.1093.
    PubMed     Abstract available



  116. Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Inflamm Bowel Dis. 2023 Oct 25:izad260. doi: 10.1093.
    PubMed    


  117. LUND K, Zegers FD, Nielsen J, Brodersen JB, et al
    Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study.
    Inflamm Bowel Dis. 2023 Oct 24:izad244. doi: 10.1093.
    PubMed     Abstract available


  118. DIMOPOULOS-VERMA A, Hong S, Axelrad JE
    Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.
    Inflamm Bowel Dis. 2023 Oct 20:izad253. doi: 10.1093.
    PubMed     Abstract available


  119. DONNELLY M, Driever D, Ryan EJ, Elliott JA, et al
    Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
    Inflamm Bowel Dis. 2023 Oct 20:izad225. doi: 10.1093.
    PubMed     Abstract available


  120. DAL BUONO A, Armuzzi A
    Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Oct 20:izad254. doi: 10.1093.
    PubMed    


  121. MASSIRONI S, Sileri P, Danese S
    Get Fit: Muscle Health for Crohn's Disease Surgical Outcome Optimization.
    Inflamm Bowel Dis. 2023 Oct 20:izad235. doi: 10.1093.
    PubMed    


  122. PRAKASH P, Dua A, Blumenfeld Y, Chen PH, et al
    Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis.
    Inflamm Bowel Dis. 2023 Oct 19:izad250. doi: 10.1093.
    PubMed     Abstract available


  123. COLLEN LV, Mitsialis V, Kim DY, Bresnahan M, et al
    Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Oct 17:izad196. doi: 10.1093.
    PubMed     Abstract available


  124. KRUGLIAK CLEVELAND N, Miyatani Y, Picker EA, Rubin DT, et al
    At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Oct 16:izad237. doi: 10.1093.
    PubMed    


  125. DALAL RS, Sharma PP, Bains K, Pruce JC, et al
    Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
    Inflamm Bowel Dis. 2023 Oct 16:izad242. doi: 10.1093.
    PubMed     Abstract available


  126. SCHMOYER CJ, Sun K, Zack J, Kumar P, et al
    Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions.
    Inflamm Bowel Dis. 2023 Oct 11:izad226. doi: 10.1093.
    PubMed     Abstract available


  127. TARIQ R, Loftus EV
    Home-based Biologic Infusions for Inflammatory Bowel Disease: Are We Ready for Prime Time?
    Inflamm Bowel Dis. 2023 Oct 11:izad240. doi: 10.1093.
    PubMed    


  128. SMITH RA, Desai A, Hashash JG, Hayney MS, et al
    Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.
    Inflamm Bowel Dis. 2023 Oct 10:izad233. doi: 10.1093.
    PubMed    


  129. MARTINELLI M, Romeo E, Caldaro T, Dimakou K, et al
    De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Inflamm Bowel Dis. 2023 Oct 10:izad199. doi: 10.1093.
    PubMed     Abstract available


  130. O'SHEA D, Picoraro JA
    De Novo Crohn's Disease in the Pediatric Pouch.
    Inflamm Bowel Dis. 2023 Oct 10:izad231. doi: 10.1093.
    PubMed     Abstract available


  131. KLEEBAYOON A, Wiwanitkit V
    SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Oct 10:izad230. doi: 10.1093.
    PubMed    



  132. Correction to: Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
    Inflamm Bowel Dis. 2023 Oct 9:izad239. doi: 10.1093.
    PubMed    


  133. REIJNTJES M, de Jong D, Wessels E, Goetgebuer R, et al
    Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential Overdiagnoses.
    Inflamm Bowel Dis. 2023 Oct 6:izad228. doi: 10.1093.
    PubMed     Abstract available


  134. RAO V, Cockburn E, Segal JP
    Is Ulcerative Colitis Really Ever "Cleared?".
    Inflamm Bowel Dis. 2023 Oct 5:izad234. doi: 10.1093.
    PubMed    


  135. LAHEIJ RLH, van Knippenberg YMW, Heil ALJ, Mannaerts BJW, et al
    The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clini
    Inflamm Bowel Dis. 2023 Oct 4:izad216. doi: 10.1093.
    PubMed     Abstract available


  136. BISLENGHI G, Van Den Bossch J, Fieuws S, Wolthuis A, et al
    Appearance of the Bowel and Mesentery During Surgery Is Not Predictive of Postoperative Recurrence After Ileocecal Resection for Crohn's Disease: A Prospective Monocentric Study.
    Inflamm Bowel Dis. 2023 Oct 4:izad227. doi: 10.1093.
    PubMed     Abstract available


  137. YANG W, Cong Y
    Exploring Colitis through Dynamic T Cell Adoptive Transfer Models.
    Inflamm Bowel Dis. 2023;29:1673-1680.
    PubMed     Abstract available


  138. YIN Y, Wan J, Yu J, Wu K, et al
    Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
    Inflamm Bowel Dis. 2023;29:1648-1657.
    PubMed     Abstract available


  139. WEIDINGER C, Siegmund B
    Deciphering Cellular Networks in Creeping Fat.
    Inflamm Bowel Dis. 2023;29:1670-1672.
    PubMed    


    September 2023
  140. TYRODE G, Lakkis Z, Vernerey D, Falcoz A, et al
    KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Sep 30:izad214. doi: 10.1093.
    PubMed     Abstract available


  141. LEE YJ, Li D, Mujukian A, Debbas P, et al
    Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Sep 29:izad198. doi: 10.1093.
    PubMed    


  142. CATASSI G, D'Arcangelo G, Norsa L, Bramuzzo M, et al
    Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2023 Sep 28:izad218. doi: 10.1093.
    PubMed     Abstract available


  143. METWALY A, Haller D
    The TNF?ARE Model of Crohn's Disease-like Ileitis.
    Inflamm Bowel Dis. 2023 Sep 26:izad205. doi: 10.1093.
    PubMed     Abstract available


  144. LIU GXH, Day AS
    Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
    Inflamm Bowel Dis. 2023 Sep 25:izad213. doi: 10.1093.
    PubMed     Abstract available


  145. PATEL R, Marrie RA, Bernstein CN, Bolton JM, et al
    Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study.
    Inflamm Bowel Dis. 2023 Sep 22:izad204. doi: 10.1093.
    PubMed     Abstract available


  146. SIGVARDSSON I, Stordal K, Ostensson M, Guo A, et al
    Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    Inflamm Bowel Dis. 2023 Sep 22:izad220. doi: 10.1093.
    PubMed     Abstract available


  147. GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
    Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?".
    Inflamm Bowel Dis. 2023 Sep 21:izad222. doi: 10.1093.
    PubMed    


  148. ERRIDGE S, Sodergren MH
    Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2023 Sep 21:izad221. doi: 10.1093.
    PubMed    


  149. BARBER GE, Zhuo J, Okafor PN, Streett S, et al
    Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Sep 21:izad207. doi: 10.1093.
    PubMed     Abstract available


  150. SNINSKY JA, Staicu AM, Barnes EL
    In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk.
    Inflamm Bowel Dis. 2023 Sep 21:izad215. doi: 10.1093.
    PubMed    


  151. LASA J, Nazario E, De Sanctis G, Fernandez Recalde M, et al
    Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2023 Sep 21:izad217. doi: 10.1093.
    PubMed     Abstract available


  152. LI WAI SUEN CFD, Seah D, Choy MC, De Cruz P, et al
    Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Sep 19:izad183. doi: 10.1093.
    PubMed     Abstract available


  153. NASEEM K, Sohail A, Quang Nguyen V, Khan A, et al
    Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
    Inflamm Bowel Dis. 2023 Sep 19:izad200. doi: 10.1093.
    PubMed     Abstract available


  154. SHAH S, Shillington AC, Kabagambe EK, Deering KL, et al
    Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey.
    Inflamm Bowel Dis. 2023 Sep 13:izad194. doi: 10.1093.
    PubMed     Abstract available


  155. GUGLIELMI G, Crucitta S, Bertani L, Ruglioni M, et al
    Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-alpha Biologics.
    Inflamm Bowel Dis. 2023 Sep 11:izad181. doi: 10.1093.
    PubMed     Abstract available


  156. DEL CHIERICO F, Cardile S, Baldelli V, Alterio T, et al
    Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Sep 11:izad203. doi: 10.1093.
    PubMed     Abstract available



  157. Correction to: Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Sep 9:izad223. doi: 10.1093.
    PubMed    


  158. MIYATANI Y, Micic D
    Revisiting the Risk of Hospital Readmission in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Sep 8:izad212. doi: 10.1093.
    PubMed    


  159. KIM SH, Buhle A, Roberts A, Singh N, et al
    Multidisciplinary Inflammatory Bowel Disease Conference: The Impact of the Expert Pathologist on Patient Care.
    Inflamm Bowel Dis. 2023 Sep 6:izad192. doi: 10.1093.
    PubMed     Abstract available


  160. SITKIN S, Pokrotnieks J
    Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Sep 6:izad209. doi: 10.1093.
    PubMed    


  161. DI MARTINO L
    Reply: "Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-Modulating Therapy for Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2023 Sep 6:izad206. doi: 10.1093.
    PubMed    


  162. SINGH A, Midha V, Kochhar GS, Shen B, et al
    Management of Perianal Fistulizing Crohn's Disease.
    Inflamm Bowel Dis. 2023 Sep 6:izad195. doi: 10.1093.
    PubMed     Abstract available


  163. CROUWEL F, Bayoumy AB, Mulder CJJ, Peters JHC, et al
    The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Sep 2:izad197. doi: 10.1093.
    PubMed     Abstract available


  164. HERRERA-DEGUISE C, Varela E, Sarrabayrouse G, Pozuelo Del Rio M, et al
    Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
    Inflamm Bowel Dis. 2023;29:1362-1369.
    PubMed     Abstract available


  165. RUTHERFORD D, Ho GT
    Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:1488-1498.
    PubMed     Abstract available


  166. NORGARD BM, Zegers FD, Nielsen J, Knudsen T, et al
    COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2023;29:1470-1476.
    PubMed     Abstract available


  167. AKIYAMA S, Cohen NA, Kayal M, Dubinsky MC, et al
    Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.
    Inflamm Bowel Dis. 2023;29:1504-1507.
    PubMed    


  168. AINSWORTH MA
    How to Minimize Placebo Response and Remission Rates.
    Inflamm Bowel Dis. 2023;29:1508-1509.
    PubMed    


  169. IACUCCI M, Jeffery L, Acharjee A, Grisan E, et al
    Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
    Inflamm Bowel Dis. 2023;29:1409-1420.
    PubMed     Abstract available


  170. OUTTIER A, Gijbels L, Noman M, Verstockt B, et al
    Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes.
    Inflamm Bowel Dis. 2023;29:1440-1445.
    PubMed     Abstract available


  171. MASSIRONI S, Pirola L, Mulinacci G, Ciaccio A, et al
    Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Inflamm Bowel Dis. 2023;29:1477-1487.
    PubMed     Abstract available


  172. CUOMO M, Carobbio A, Aloi M, Alvisi P, et al
    Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
    Inflamm Bowel Dis. 2023;29:1380-1389.
    PubMed     Abstract available


    August 2023
  173. LIU T, Lin CH, Chen YL, Yeh CC, et al
    Relationship Between Rectal Swab and Tissue Samples in Mucosa-associated Microbiota in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Aug 31:izad179. doi: 10.1093.
    PubMed     Abstract available


  174. BHAT S, Lyu R, Agarwal M, Becker M, et al
    Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
    Inflamm Bowel Dis. 2023 Aug 31:izad143. doi: 10.1093.
    PubMed     Abstract available


  175. JACOBS JP, Sauk JS, Ahdoot AI, Liang F, et al
    Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk.
    Inflamm Bowel Dis. 2023 Aug 31:izad185. doi: 10.1093.
    PubMed     Abstract available


  176. YU N, Wu K, Samyue T, Fry S, et al
    Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service.
    Inflamm Bowel Dis. 2023 Aug 29:izad145. doi: 10.1093.
    PubMed     Abstract available


  177. TOKUSHIMA K, Jimbo K, Suzuki M, Endo Y, et al
    Differentiation of Active Ulcerative Colitis vs Noninflammatory Bowel Disease Proctitis by Transperineal Superb Microvascular Imaging.
    Inflamm Bowel Dis. 2023 Aug 29:izad186. doi: 10.1093.
    PubMed     Abstract available


  178. REN H, Kang J, Wang J, Su J, et al
    Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.
    Inflamm Bowel Dis. 2023 Aug 24:izad184. doi: 10.1093.
    PubMed     Abstract available


  179. MOULTON CD, Jordan C, Hayee B, Chalder T, et al
    All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 24:izad193. doi: 10.1093.
    PubMed    


  180. DALAL RS, Sharma PP, Bains K, Pruce JC, et al
    1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States.
    Inflamm Bowel Dis. 2023 Aug 24:izad165. doi: 10.1093.
    PubMed    


  181. WANDS DIF, Gianolio L, Wilson DC, Hansen R, et al
    Nationwide Real-World Exclusive Enteral Nutrition Practice Over Time: Persistence of Use as Induction for Pediatric Crohn's Disease and Emerging Combination Strategy With Biologics.
    Inflamm Bowel Dis. 2023 Aug 24:izad167. doi: 10.1093.
    PubMed     Abstract available


  182. LONG MD, Parlett L, Lewis JD, Haynes K, et al
    Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Aug 23:izad176. doi: 10.1093.
    PubMed     Abstract available


  183. ZINGER CH, Ringel Y, Eitan M, Openhaim M, et al
    Upadacitinib for Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Aug 23:izad180. doi: 10.1093.
    PubMed    


  184. BROWNSON E, Saunders J, Jatkowska A, White B, et al
    Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2023 Aug 23:izad174. doi: 10.1093.
    PubMed     Abstract available


  185. MARTINEZ-DOMINGUEZ SJ, Garcia-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, et al
    Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
    Inflamm Bowel Dis. 2023 Aug 22:izad175. doi: 10.1093.
    PubMed     Abstract available


  186. TRACY MS, Challa PK, Lopes EW, Khalili H, et al
    Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program.
    Inflamm Bowel Dis. 2023 Aug 21:izad170. doi: 10.1093.
    PubMed    


  187. COONEY R, Tang D, Barrett K, Russell RK, et al
    Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 21:izad169. doi: 10.1093.
    PubMed     Abstract available


  188. TRAVIS S, Potts Bleakman A, Dubinsky MC, Schreiber S, et al
    The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Aug 21:izad142. doi: 10.1093.
    PubMed     Abstract available


  189. D'ARCANGELO G, Russo G, Aloi M, Ruggiero C, et al
    A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.
    Inflamm Bowel Dis. 2023 Aug 21:izad173. doi: 10.1093.
    PubMed     Abstract available


  190. RASMUSSEN J, Norgard BM, Nielsen RG, Boggild H, et al
    Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 21:izad157. doi: 10.1093.
    PubMed     Abstract available


  191. OSHIMA N, Hiraoka S, Hayashi R, Takahashi S, et al
    Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 19:izad150. doi: 10.1093.
    PubMed     Abstract available


  192. HANZEL J, Ma C, De Silva TA, Alphonsus L, et al
    Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration.
    Inflamm Bowel Dis. 2023 Aug 17:izad168. doi: 10.1093.
    PubMed    


  193. GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
    The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 14:izad151. doi: 10.1093.
    PubMed     Abstract available


  194. ZHU Z, Jia Y, Li FR, Li Y, et al
    Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes.
    Inflamm Bowel Dis. 2023 Aug 14:izad163. doi: 10.1093.
    PubMed     Abstract available


  195. MUJUKIAN A, Kumar R, Li D, Debbas P, et al
    Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
    Inflamm Bowel Dis. 2023 Aug 9:izad114. doi: 10.1093.
    PubMed     Abstract available


  196. D'AMICO F, Magro F, Siegmund B, Kobayashi T, et al
    Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus.
    Inflamm Bowel Dis. 2023 Aug 7:izad159. doi: 10.1093.
    PubMed     Abstract available


  197. RESAL T, Bacsur P, Keresztes C, Balint A, et al
    Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
    Inflamm Bowel Dis. 2023 Aug 5:izad135. doi: 10.1093.
    PubMed     Abstract available


  198. DUBOIS KE, Blake CE, Rudisill C, Harrison SE, et al
    Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort.
    Inflamm Bowel Dis. 2023 Aug 5:izad139. doi: 10.1093.
    PubMed     Abstract available


  199. DI PETRILLO A, Kumar A, Onali S, Favale A, et al
    GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Aug 5:izad161. doi: 10.1093.
    PubMed     Abstract available


  200. SHEHAB M, Al Akram S, Hassan A, Alrashed F, et al
    Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2023 Aug 4:izad119. doi: 10.1093.
    PubMed     Abstract available


  201. DESAI A, Soni A, Hayney MS, Hashash JG, et al
    Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study.
    Inflamm Bowel Dis. 2023 Aug 4:izad162. doi: 10.1093.
    PubMed     Abstract available


  202. WANG Q, Chen F, Peng Y, Yi X, et al
    Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Aug 4:izad153. doi: 10.1093.
    PubMed     Abstract available


  203. VIGANO C, Palermo A, Mulinacci G, Pirola L, et al
    Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).
    Inflamm Bowel Dis. 2023 Aug 3:izad146. doi: 10.1093.
    PubMed     Abstract available


  204. ALDARS-GARCIA L, Gil-Redondo R, Embade N, Riestra S, et al
    Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naive Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Aug 3:izad154. doi: 10.1093.
    PubMed     Abstract available


  205. ZHU N, Zhu J, Mei Q
    Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD.
    Inflamm Bowel Dis. 2023;29:e31.
    PubMed    


  206. XIE K, Ortiz Cerda T, Schroder A, Shiung N, et al
    Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD.
    Inflamm Bowel Dis. 2023;29:e32.
    PubMed    


  207. BAMIAS G, Kitsou K, Rivera-Nieves J
    The Underappreciated Role of Secretory IgA in IBD.
    Inflamm Bowel Dis. 2023;29:1327-1341.
    PubMed     Abstract available


  208. ROSEIRA J, Santiago M, Estevinho MM, Moreira P, et al
    Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2023;29:1231-1243.
    PubMed     Abstract available


  209. KAMP KJ, Hawes SE, Tse CS, Singh S, et al
    Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment.
    Inflamm Bowel Dis. 2023;29:1255-1262.
    PubMed     Abstract available


  210. PRAY C, Wong ECL, Aruljothy A, Dulai PS, et al
    Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.
    Inflamm Bowel Dis. 2023;29:1263-1271.
    PubMed     Abstract available


    July 2023
  211. CROWLEY E, Ma C, Guizzetti L, Zou G, et al
    Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
    Inflamm Bowel Dis. 2023 Jul 31:izad134. doi: 10.1093.
    PubMed     Abstract available


  212. MARK-CHRISTENSEN A, Kristiansen EB, Myrelid P, Laurberg S, et al
    Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
    Inflamm Bowel Dis. 2023 Jul 31:izad141. doi: 10.1093.
    PubMed     Abstract available


  213. OTTEN AT, Dijkstra G, Visschedijk MC, Bourgonje AR, et al
    The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients.
    Inflamm Bowel Dis. 2023 Jul 31:izad144. doi: 10.1093.
    PubMed    


  214. DALAL RS, Lund K, Zegers FD, Friedman S, et al
    Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
    Inflamm Bowel Dis. 2023 Jul 31:izad156. doi: 10.1093.
    PubMed     Abstract available


  215. BOKEMEYER B, Plachta-Danielzik S, di Giuseppe R, Efken P, et al
    Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naive Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
    Inflamm Bowel Dis. 2023 Jul 31:izad138. doi: 10.1093.
    PubMed     Abstract available


  216. LAW CCY, Tkachuk B, Lieto S, Narula N, et al
    Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2023 Jul 28:izad149. doi: 10.1093.
    PubMed     Abstract available


  217. OKITA M, Nakashima K, Yamamura T, Matsui S, et al
    Systematic Review and Meta-Analysis of the Use of Serum Leucine-Rich Alpha-2 Glycoprotein to Assess Crohn's Disease Activity.
    Inflamm Bowel Dis. 2023 Jul 28:izad128. doi: 10.1093.
    PubMed     Abstract available


  218. LEE S, Seow CH, Nerenberg K, Bertazzon S, et al
    Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
    Inflamm Bowel Dis. 2023 Jul 27:izad147. doi: 10.1093.
    PubMed     Abstract available


  219. DALAL RS, Kallumkal G, Cabral HJ, Bachour S, et al
    Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
    Inflamm Bowel Dis. 2023 Jul 27:izad155. doi: 10.1093.
    PubMed    


  220. MCNAMARA J, Connor SJ, Andrews JM
    The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform.
    Inflamm Bowel Dis. 2023 Jul 25:izad148. doi: 10.1093.
    PubMed    


  221. MARAFINI I, De Cristofaro E, Salvatori S, Calabrese E, et al
    Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study.
    Inflamm Bowel Dis. 2023 Jul 21:izad125. doi: 10.1093.
    PubMed     Abstract available


  222. ALIZADEH M, Ali O, Cross RK
    Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jul 21:izad131. doi: 10.1093.
    PubMed     Abstract available


  223. ROMANO D, Chesterman S, Fuller-Tyszkiewicz M, Evans S, et al
    Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress.
    Inflamm Bowel Dis. 2023 Jul 21:izad122. doi: 10.1093.
    PubMed     Abstract available


  224. PASCUAL-OLIVER A, Casas-Deza D, Cuaran C, Garcia-Lopez S, et al
    HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Jul 18:izad130. doi: 10.1093.
    PubMed     Abstract available


  225. LIU F, Xu W, Wang Y, Huang Z, et al
    LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jul 15:izad140. doi: 10.1093.
    PubMed     Abstract available


  226. MCHENRY S, Glover M, Ahmed A, Alayo Q, et al
    NAFLD Is Associated With Quiescent Rather Than Active Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jul 15:izad129. doi: 10.1093.
    PubMed     Abstract available


  227. BHAT S, Click B, Regueiro M
    Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
    Inflamm Bowel Dis. 2023 Jul 14:izad120. doi: 10.1093.
    PubMed     Abstract available


  228. ROOSENBOOM B, Wahab PJ, Smids C, Meijer J, et al
    Mucosal alpha4beta7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Jul 12:izad123. doi: 10.1093.
    PubMed     Abstract available


  229. KOGAN L, Townsend MJ, Raj D, Levy AN, et al
    Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2023 Jul 8:izad121. doi: 10.1093.
    PubMed    


  230. ZENG Z, Cheng S, Li X, Liu H, et al
    Glycolytic Activation of CD14+ Intestinal Macrophages Contributes to the Inflammatory Responses via Exosomal Membrane Tumor Necrosis Factor in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jul 5:izad117. doi: 10.1093.
    PubMed     Abstract available


  231. DAI C, Huang YH
    Frail Phenotype in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023;29:e30.
    PubMed    


  232. RAUSCH P, Ellul S, Pisani A, Bang C, et al
    Microbial Dynamics in Newly Diagnosed and Treatment Naive IBD Patients in the Mediterranean.
    Inflamm Bowel Dis. 2023;29:1118-1132.
    PubMed     Abstract available


  233. GARCIA-HERNANDEZ V, Raya-Sandino A, Azcutia V, Miranda J, et al
    Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair.
    Inflamm Bowel Dis. 2023;29:1133-1144.
    PubMed     Abstract available


  234. LAM GA, Albarrak H, McColl CJ, Pizarro A, et al
    The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders.
    Inflamm Bowel Dis. 2023;29:1153-1164.
    PubMed     Abstract available


  235. ADLER J, Colletti RB, Noonan L, Berzin TM, et al
    Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity.
    Inflamm Bowel Dis. 2023;29:1089-1097.
    PubMed     Abstract available


  236. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Young Adult Male Patients With Childhood-onset IBD Have Increased Risks of Compromised Cortical and Trabecular Bone Microstructures.
    Inflamm Bowel Dis. 2023;29:1065-1072.
    PubMed     Abstract available


  237. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naive Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:1015-1023.
    PubMed     Abstract available


  238. PROIETTI E, Pauwels RWM, van der Woude CJ, Doukas M, et al
    Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction.
    Inflamm Bowel Dis. 2023;29:1038-1046.
    PubMed     Abstract available


  239. CHANDAN S, Dhindsa BS, Khan SR, Deliwala S, et al
    Endoscopic Stenting in Crohn's Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes.
    Inflamm Bowel Dis. 2023;29:1145-1152.
    PubMed     Abstract available


    June 2023
  240. MACALUSO FS, Principi M, Facciotti F, Contaldo A, et al
    Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.
    Inflamm Bowel Dis. 2023 Jun 30:izad118. doi: 10.1093.
    PubMed    


  241. ADIMADHYAM S, Lewis JD, Simon AL, Wolfe AE, et al
    Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Jun 26:izad115. doi: 10.1093.
    PubMed     Abstract available


  242. WONG SY, Wellens J, Helmus D, Marlow L, et al
    Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
    Inflamm Bowel Dis. 2023 Jun 24:izad097. doi: 10.1093.
    PubMed     Abstract available


  243. ITO N, Kudo T, Eguchi H, Jimbo K, et al
    Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jun 16:izad116. doi: 10.1093.
    PubMed     Abstract available


  244. TE GROEN M, Derikx LAAP, van Lierop L, Ylstra B, et al
    Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.
    Inflamm Bowel Dis. 2023 Jun 16:izad112. doi: 10.1093.
    PubMed    


  245. MULES TC, Lavender B, Maclean K, Vacca F, et al
    Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial.
    Inflamm Bowel Dis. 2023 Jun 15:izad110. doi: 10.1093.
    PubMed     Abstract available


  246. SEHGAL P, Su S, Zech J, Nobel Y, et al
    Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
    Inflamm Bowel Dis. 2023 Jun 12:izad111. doi: 10.1093.
    PubMed     Abstract available


  247. TANEJA V, Anand RS, El-Dallal M, Dong J, et al
    Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2023 Jun 10:izad108. doi: 10.1093.
    PubMed     Abstract available


  248. ODUFALU FD, Dubinsky MC, Peyrin-Biroulet L, Ylanne K, et al
    Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
    Inflamm Bowel Dis. 2023 Jun 10:izad102. doi: 10.1093.
    PubMed     Abstract available


  249. RHUDY CN, Perry CL, Hawk GS, Flomenhoft DR, et al
    Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.
    Inflamm Bowel Dis. 2023 Jun 6:izad096. doi: 10.1093.
    PubMed     Abstract available


  250. SCALDAFERRI F, D'Onofrio AM, Calia R, Di Vincenzo F, et al
    Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center.
    Inflamm Bowel Dis. 2023 Jun 6:izad091. doi: 10.1093.
    PubMed     Abstract available


  251. SUTTICHAIMONGKOL T, Loftus EV
    Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jun 6:izad104. doi: 10.1093.
    PubMed     Abstract available


  252. SARTER H, Savoye G, Marot G, Ley D, et al
    A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.
    Inflamm Bowel Dis. 2023 Jun 2:izad090. doi: 10.1093.
    PubMed     Abstract available


  253. OTTEN AT, van der Meulen HH, Steenhuis M, Loeff FC, et al
    Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jun 2:izad103. doi: 10.1093.
    PubMed     Abstract available


  254. LIGHTNER AL, Otero-Pineiro A, Reese J, Ream J, et al
    A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jun 1:izad100. doi: 10.1093.
    PubMed     Abstract available


  255. CARPINETI C, Mugheddu C, Cadoni M, Anedda J, et al
    Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab.
    Inflamm Bowel Dis. 2023 Jun 1:izad107. doi: 10.1093.
    PubMed    


  256. KHROM M, Li D, Naito T, Lee HS, et al
    Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jun 1:izad089. doi: 10.1093.
    PubMed     Abstract available


  257. EL HAJJ W, Buisson A, Olympie A, Ravel MH, et al
    Impact of Inflammatory Bowel Disease on Patients' Caregivers: Results From a French Survey.
    Inflamm Bowel Dis. 2023 Jun 1:izad093. doi: 10.1093.
    PubMed     Abstract available


  258. TSOUNIS EP, Aggeletopoulou I, Mouzaki A, Triantos C, et al
    Creeping Fat in the Pathogenesis of Crohn's Disease: An Orchestrator or a Silent Bystander?
    Inflamm Bowel Dis. 2023 Jun 1:izad095. doi: 10.1093.
    PubMed     Abstract available


  259. HONG SN, Song JH, Kim SJ, Park YH, et al
    One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2023 Jun 1:izad094. doi: 10.1093.
    PubMed     Abstract available


  260. KARIME C, Farraye FA, Hashash JG
    Use of Immune Checkpoint Inhibitors in Patients With Inflammatory Bowel Disease After Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2023 Jun 1:izad098. doi: 10.1093.
    PubMed    


  261. CUSHING KC, Chen Y, Du X, Chen V, et al
    Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases.
    Inflamm Bowel Dis. 2023;29:938-945.
    PubMed     Abstract available


  262. SOUSA P, Noor NM
    Revisiting Drug Development for Older Molecules in IBD.
    Inflamm Bowel Dis. 2023;29:1012-1013.
    PubMed    


  263. BOUHNIK Y, Atreya R, Casey D, Gorecki M, et al
    Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment.
    Inflamm Bowel Dis. 2023;29:898-913.
    PubMed     Abstract available


  264. RIVIERE P, Kanters C, Pellet G, Ni A, et al
    Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
    Inflamm Bowel Dis. 2023;29:923-931.
    PubMed     Abstract available


  265. SHORE BM, Weaver KN, Allegretti JR, Herfarth HH, et al
    Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn's-like Disease of the Pouch.
    Inflamm Bowel Dis. 2023;29:932-937.
    PubMed     Abstract available


  266. AXELRAD JE, Li T, Bachour SP, Nakamura TI, et al
    Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
    Inflamm Bowel Dis. 2023;29:888-897.
    PubMed     Abstract available


  267. FAN Y, Zhang L, Omidakhsh N, Bohn RL, et al
    Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
    Inflamm Bowel Dis. 2023;29:914-922.
    PubMed     Abstract available


  268. WONG ECL, Yusuf A, Pokryszka J, Dulai PS, et al
    Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:875-882.
    PubMed     Abstract available


  269. SEDANO R, Guizzetti L, McDonald C, Beaton M, et al
    Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naive Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center.
    Inflamm Bowel Dis. 2023;29:866-874.
    PubMed     Abstract available


    May 2023
  270. HSU P, Choi EJ, Patel SA, Wong WH, et al
    Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
    Inflamm Bowel Dis. 2023 May 26:izad084. doi: 10.1093.
    PubMed     Abstract available


  271. CHAVANNES M, Hart L, Hayati Rezvan P, Dillman JR, et al
    Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study.
    Inflamm Bowel Dis. 2023 May 25:izad083. doi: 10.1093.
    PubMed     Abstract available


  272. HSIA K, Zhao N, Chung M, Algarrahi K, et al
    Alterations in the Fungal Microbiome in Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 May 23:izad082. doi: 10.1093.
    PubMed     Abstract available


  273. DALAL RS, Sharma PP, Bains K, Pruce JC, et al
    1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
    Inflamm Bowel Dis. 2023 May 20:izad087. doi: 10.1093.
    PubMed     Abstract available


  274. LOEB L, Nasir A, Picco MF, Hashash JG, et al
    Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 May 17:izad088. doi: 10.1093.
    PubMed    


  275. MA R, Zhu Y, Li X, Hu S, et al
    A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2023 May 17:izad080. doi: 10.1093.
    PubMed     Abstract available


  276. KOPYLOV U, Burisch J, Ben-Horin S, Braegger F, et al
    Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study.
    Inflamm Bowel Dis. 2023 May 9:izad075. doi: 10.1093.
    PubMed     Abstract available


  277. MCDONALD C, Kerr H, Gibbons E, Lukose T, et al
    Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn's Disease: An Experience of 2 IBD Centers.
    Inflamm Bowel Dis. 2023 May 9:izad073. doi: 10.1093.
    PubMed     Abstract available


  278. CHEN X, Elson CO, Dunkin D
    Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.
    Inflamm Bowel Dis. 2023;29:798-807.
    PubMed     Abstract available


  279. LAI HJ, Doan HT, Lin EY, Chiu YL, et al
    Histones of Neutrophil Extracellular Traps Directly Disrupt the Permeability and Integrity of the Intestinal Epithelial Barrier.
    Inflamm Bowel Dis. 2023;29:783-797.
    PubMed     Abstract available


  280. CAO H, Diao J, Liu H, Liu S, et al
    The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:818-829.
    PubMed     Abstract available


  281. BEZZIO C, Fiorino G, Ribaldone DG, Armuzzi A, et al
    IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame.
    Inflamm Bowel Dis. 2023;29:834-836.
    PubMed    


  282. DALAL RS, Pruce JC, Allegretti JR
    Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:830-833.
    PubMed    


  283. HUTFLESS S, Jasper RA, Tilak A, Ghosh T, et al
    A Systematic Review of Crohn's Disease Case Definitions in Administrative or Claims Databases.
    Inflamm Bowel Dis. 2023;29:705-715.
    PubMed     Abstract available


  284. CHAN M, Fung M, Chin Koon Siw K, Khanna R, et al
    Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
    Inflamm Bowel Dis. 2023;29:763-770.
    PubMed     Abstract available


  285. HOLKO P, Kawalec P, Sajak-Szczerba M, Avedano L, et al
    Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.
    Inflamm Bowel Dis. 2023;29:752-762.
    PubMed     Abstract available


  286. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:716-725.
    PubMed     Abstract available


    April 2023
  287. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.
    Inflamm Bowel Dis. 2023 Apr 28:izad074. doi: 10.1093.
    PubMed     Abstract available


  288. ZITTAN E, Mahajna H, Salomon N
    Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts.
    Inflamm Bowel Dis. 2023 Apr 28:izad072. doi: 10.1093.
    PubMed    


  289. GKIKAS K, Wan M, Svolos V, Nichols B, et al
    YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Apr 26:izad076. doi: 10.1093.
    PubMed     Abstract available


  290. ATIA O, Magen Rimon R, Ledderman N, Greenfeld S, et al
    Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
    Inflamm Bowel Dis. 2023 Apr 21:izad057. doi: 10.1093.
    PubMed     Abstract available


  291. YANG X, Shi J, Wang G, Chen H, et al
    Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Apr 20:izad060. doi: 10.1093.
    PubMed     Abstract available


  292. MCBRIDE RB, Suarez-Farinas M, Ko HM, Chen X, et al
    Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Apr 19:izad063. doi: 10.1093.
    PubMed     Abstract available


  293. YANG Y, Carrero JJ
    Reply: Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
    Inflamm Bowel Dis. 2023 Apr 19:izad069. doi: 10.1093.
    PubMed    


  294. LIU M, Ye Z, Sun Z
    Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
    Inflamm Bowel Dis. 2023 Apr 19:izad067. doi: 10.1093.
    PubMed    


  295. SCHELL TL, Ramirez O, Almasry M, Farraye FA, et al
    Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Apr 18:izad068. doi: 10.1093.
    PubMed    


  296. VASUDEVAN A, Tharayil V, Raffals LH, Bruining DH, et al
    Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Apr 18:izad065. doi: 10.1093.
    PubMed     Abstract available


  297. NOURELDIN M, Newman KL, Higgins PDR, Piette JD, et al
    Profiles of Web-based Portal Users with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Apr 18:izad056. doi: 10.1093.
    PubMed     Abstract available


  298. DAWWAS GK, Weiss A, Constant BD, Parlett LE, et al
    Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.
    Inflamm Bowel Dis. 2023 Apr 12:izad053. doi: 10.1093.
    PubMed     Abstract available


  299. YERUSHALMY-FELER A, Olbjorn C, Kolho KL, Aloi M, et al
    Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2023 Apr 12:izad064. doi: 10.1093.
    PubMed     Abstract available


  300. KILIC Y, Kamal S, Jaffar F, Sriranganathan D, et al
    Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2023 Apr 12:izad061. doi: 10.1093.
    PubMed     Abstract available


  301. LOLY JP, Vieujean S, Reenaers C, Van Kemseke C, et al
    In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab.
    Inflamm Bowel Dis. 2023 Apr 12:izad066. doi: 10.1093.
    PubMed     Abstract available


  302. TSE CS, Weng CH, Kwon M, Wolk CB, et al
    Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017.
    Inflamm Bowel Dis. 2023 Apr 7:izad062. doi: 10.1093.
    PubMed    


  303. CHEN D, Tang H, Li Y, Yang H, et al
    Vitamin D3 and Lactobacillus rhamnosus GG/p40 Synergize to Protect Mice From Colitis by Promoting Vitamin D Receptor Expression and Epithelial Proliferation.
    Inflamm Bowel Dis. 2023;29:620-632.
    PubMed     Abstract available


  304. ASHTON JJ, Cheng G, Stafford IS, Kellermann M, et al
    Prediction of Crohn's Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker.
    Inflamm Bowel Dis. 2023;29:511-521.
    PubMed     Abstract available


  305. NOOR NM, Lee JC
    The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity.
    Inflamm Bowel Dis. 2023;29:669-671.
    PubMed    


  306. HOLMER AK, Boland BS, Singh S, Neill J, et al
    A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:555-562.
    PubMed     Abstract available


  307. PARK J, Chun J, Yoon H, Cheon JH, et al
    Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study.
    Inflamm Bowel Dis. 2023;29:548-554.
    PubMed     Abstract available


  308. RISPO A, de Sire R, Mainenti PP, Imperatore N, et al
    David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:563-569.
    PubMed     Abstract available


  309. D'AMICO F, Tasopoulou O, Fiorino G, Zilli A, et al
    Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
    Inflamm Bowel Dis. 2023;29:539-547.
    PubMed     Abstract available


  310. VUYYURU SK, Nguyen TM, Hogan M, Raine T, et al
    Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2023 Apr 1:izad052. doi: 10.1093.
    PubMed     Abstract available


    March 2023
  311. DENG L, He S, Li Y, Ding R, et al
    Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Mar 31:izad050. doi: 10.1093.
    PubMed     Abstract available


  312. DERKS MEW, van Lierop LMA, Te Groen M, Kuijpers CCHJ, et al
    Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update.
    Inflamm Bowel Dis. 2023 Mar 31:izad055. doi: 10.1093.
    PubMed    


  313. TANDON P, Chhibba T, Natt N, Singh Brar G, et al
    Significant Racial and Ethnic Disparities Exist in Health Care Utilization in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2023 Mar 28:izad045. doi: 10.1093.
    PubMed     Abstract available


  314. AKIYA A, Takahashi K, Akimoto S, Hosono Y, et al
    Novel Findings of Early Cardiac Dysfunction in Patients With Childhood-Onset Inflammatory Bowel Disease Using Layer-Specific Strain Analysis.
    Inflamm Bowel Dis. 2023 Mar 27:izad031. doi: 10.1093.
    PubMed     Abstract available


  315. ANYANE-YEBOA A, Buadu MAE, Khalili H, Cozier YC, et al
    Epidemiology of Inflammatory Bowel Disease in a Cohort of US Black Women.
    Inflamm Bowel Dis. 2023 Mar 22:izad049. doi: 10.1093.
    PubMed     Abstract available


  316. LU X, Zhou ZY, Xin Y, Wang MJ, et al
    Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Mar 22:izad037. doi: 10.1093.
    PubMed     Abstract available


  317. KAYAL M, Posner H, Milwidsky HM, Plietz M, et al
    Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis.
    Inflamm Bowel Dis. 2023 Mar 20:izad039. doi: 10.1093.
    PubMed     Abstract available


  318. RABINOWITZ LG
    Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.
    Inflamm Bowel Dis. 2023 Mar 18:izad047. doi: 10.1093.
    PubMed    


  319. COLLEN LV
    Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2023 Mar 18:izad048. doi: 10.1093.
    PubMed    


  320. GOODSALL TM, Day AS, Andrews JM, Ruszkiewicz A, et al
    Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study.
    Inflamm Bowel Dis. 2023 Mar 16:izad043. doi: 10.1093.
    PubMed     Abstract available


  321. MARRIE RA, Fisk JD, Dolovich C, Lix LM, et al
    Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Mar 14:izad038. doi: 10.1093.
    PubMed     Abstract available


  322. VARMA S, Trudeau SJ, Li J, Freedberg DE, et al
    Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
    Inflamm Bowel Dis. 2023 Mar 14:izad035. doi: 10.1093.
    PubMed     Abstract available


  323. BUIE MJ, Coward S, Shaheen AA, Holroyd-Leduc J, et al
    Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2023 Mar 14:izad020. doi: 10.1093.
    PubMed     Abstract available


  324. AGOSTINI A, Benuzzi F, Ballotta D, Rizzello F, et al
    Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages.
    Inflamm Bowel Dis. 2023 Mar 10:izad029. doi: 10.1093.
    PubMed     Abstract available


  325. ALMOMEN HS, Al-Bawardy B
    Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation.
    Inflamm Bowel Dis. 2023 Mar 8:izad040. doi: 10.1093.
    PubMed    


  326. LIU R, Li Z, Ye L, Hu J, et al
    Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn's Disease on Ustekinumab: A Nationwide Real-World Study.
    Inflamm Bowel Dis. 2023 Mar 6:izad032. doi: 10.1093.
    PubMed     Abstract available


  327. KUNISAKI R, Ikeda A, Yaguchi K, Onishi M, et al
    To Be in Remission or in Corticosteroid-free Remission: That Is the Question for Women With Inflammatory Bowel Disease at Conception.
    Inflamm Bowel Dis. 2023 Mar 6:izad023. doi: 10.1093.
    PubMed    


  328. MOURAD FH, Maalouf RG, Aoun R, Gustavo Kotze P, et al
    Are the New Biologics Effective in the Management of Postoperative Crohn's Disease?
    Inflamm Bowel Dis. 2023 Mar 4:izad033. doi: 10.1093.
    PubMed     Abstract available


  329. SCHROEDER MK, Tan SA, Touma MJ, Basit M, et al
    Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions.
    Inflamm Bowel Dis. 2023 Mar 2:izad026. doi: 10.1093.
    PubMed    


  330. CHIBA M, Hosoba M, Yamada K
    Plant-Based Diet Recommended for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Mar 1:izac279. doi: 10.1093.
    PubMed    


  331. LIMKETKAI BN
    Reply: Plant-Based Diet Recommended for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Mar 1:izad022. doi: 10.1093.
    PubMed    


  332. GEERTSEMA S, Otten AT, Bouwknegt DG, Visschedijk MC, et al
    Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:e10-e11.
    PubMed    


  333. MASSELOT CR, Cordier C, Marsac B, Nachury M, et al
    Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:e12.
    PubMed    


  334. CHIRRA P, Sharma A, Bera K, Cohn HM, et al
    Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study.
    Inflamm Bowel Dis. 2023;29:349-358.
    PubMed     Abstract available


  335. MCKENNA NP, Kelley SR, Bews KA, Behm KT, et al
    Surgical Management of Enterovesical Fistula in Crohn's Disease in the Biologic Era.
    Inflamm Bowel Dis. 2023;29:480-482.
    PubMed    


  336. GU P, Dube S, McGovern DPB
    Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature.
    Inflamm Bowel Dis. 2023;29:458-469.
    PubMed     Abstract available


  337. SHEHAB M, Alrashed F, Heron V, Restellini S, et al
    Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Inflamm Bowel Dis. 2023;29:367-375.
    PubMed     Abstract available


  338. TURSI A, Mocci G, Allegretta L, Aragona G, et al
    Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
    Inflamm Bowel Dis. 2023;29:376-383.
    PubMed     Abstract available


  339. KASSIM G, Yzet C, Nair N, Debebe A, et al
    Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.
    Inflamm Bowel Dis. 2023;29:417-422.
    PubMed     Abstract available


    February 2023
  340. AYOUB M, Shah H, Nguyen BC, Mehdi M, et al
    Coronary Artery Plaque Assessment by CT Angiogram in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Feb 24:izad036. doi: 10.1093.
    PubMed    


  341. URQUHART SA, Comstock BP, Jin MF, Day CN, et al
    The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Feb 22:izad021. doi: 10.1093.
    PubMed     Abstract available


  342. AL-BAWARDY B, Malter L, Ehrlich AC, Rieder F, et al
    Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows.
    Inflamm Bowel Dis. 2023 Feb 22:izad030. doi: 10.1093.
    PubMed    


  343. BURSTINER LS, Owings AH, Royer A, Hreish Y, et al
    Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.
    Inflamm Bowel Dis. 2023 Feb 21:izad005. doi: 10.1093.
    PubMed     Abstract available


  344. VALVANO M, Vinci A, Latella G
    Reply: Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Feb 17:izad028. doi: 10.1093.
    PubMed    


  345. DAI C, Huang YH
    Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2023 Feb 17:izad025. doi: 10.1093.
    PubMed    


  346. BRAMUZZO M, Giudici F, Arrigo S, Lionetti P, et al
    Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Feb 17:izad018. doi: 10.1093.
    PubMed     Abstract available


  347. CARTER D, Albshesh A, Shimon C, Segal B, et al
    Automatized Detection of Crohn's Disease in Intestinal Ultrasound Using Convolutional Neural Network.
    Inflamm Bowel Dis. 2023 Feb 16:izad014. doi: 10.1093.
    PubMed     Abstract available


  348. SINGH N, Nugent Z, Singh H, Shaffer SR, et al
    Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Feb 15:izad017. doi: 10.1093.
    PubMed     Abstract available


  349. DANESE S, Tran J, D'Haens G, Rubin DT, et al
    Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
    Inflamm Bowel Dis. 2023 Feb 15:izad016. doi: 10.1093.
    PubMed     Abstract available


  350. CALDERA F, Richard L, Almasry M, Phan H, et al
    Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Feb 15:izad019. doi: 10.1093.
    PubMed    


  351. YOUSSEF M, Dong K, Lee SJ, Narula N, et al
    Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2023 Feb 8:izad013. doi: 10.1093.
    PubMed     Abstract available


  352. LOVEIKYTE R, Bourgonje AR, van der Reijden JJ, Bulthuis MLC, et al
    Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab.
    Inflamm Bowel Dis. 2023 Feb 7:izad010. doi: 10.1093.
    PubMed     Abstract available


  353. HORRIGAN J, Tadros M
    Novel Patient-centered Educational Panel Enhances Preclinical Medical Student Understanding of IBD Beyond What Can Be Learned in a Traditional Classroom.
    Inflamm Bowel Dis. 2023;29:e3-e4.
    PubMed    


  354. JELINSKY SA, Derksen M, Bauman E, Verissimo CS, et al
    Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
    Inflamm Bowel Dis. 2023;29:195-206.
    PubMed     Abstract available


  355. JACOBS J, Clark-Snustad K, Lee S
    Deep Remission in Severe Refractory Crohn's Disease With Mycophenolate Mofetil.
    Inflamm Bowel Dis. 2023;29:332-333.
    PubMed    


  356. MADDIPATLA SC, Kolachala VL, Venkateswaran S, Dodd AF, et al
    Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naive and Treated Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:274-285.
    PubMed     Abstract available


  357. KAWAMURA T, Yamamura T, Nakamura M, Maeda K, et al
    Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:245-253.
    PubMed     Abstract available


  358. ZACHAROPOULOU E, Orfanoudaki E, Tzouvala M, Tribonias G, et al
    Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
    Inflamm Bowel Dis. 2023;29:228-237.
    PubMed     Abstract available


  359. BUISSON A, Blanco L, Manlay L, Reymond M, et al
    Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:185-194.
    PubMed     Abstract available


    January 2023
  360. LI C, Xu Y, Gao T, Zhang S, et al
    Ruxolitinib Alleviates Inflammation, Apoptosis, and Intestinal Barrier Leakage in Ulcerative Colitis via STAT3.
    Inflamm Bowel Dis. 2023 Jan 31:izad007. doi: 10.1093.
    PubMed     Abstract available


  361. ERTEM FU, Rivers CR, Watson AR, Tang G, et al
    Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jan 31:izad008. doi: 10.1093.
    PubMed     Abstract available


  362. SALVATORI S, Monteleone G
    Reply: Frail Phenotype in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jan 31:izad015. doi: 10.1093.
    PubMed    


  363. SEMPERE L, Bernabeu P, Cameo J, Gutierrez A, et al
    Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.
    Inflamm Bowel Dis. 2023 Jan 31:izad001. doi: 10.1093.
    PubMed     Abstract available


  364. CHOI DK, Cohen NA, Choden T, Cohen RD, et al
    Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Jan 30:izad012. doi: 10.1093.
    PubMed    


  365. GISBERT JP, Parody-Rua E, Chaparro M
    Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review.
    Inflamm Bowel Dis. 2023 Jan 28:izac275. doi: 10.1093.
    PubMed     Abstract available


  366. SHU W, Wang Y, Li C, Zhang L, et al
    Single-cell Expression Atlas Reveals Cell Heterogeneity in the Creeping Fat of Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jan 28:izac266. doi: 10.1093.
    PubMed     Abstract available


  367. DI MARTINO L, Osme A, Ghannoum M, Cominelli F, et al
    A Novel Probiotic Combination Ameliorates Crohn's Disease-Like Ileitis by Increasing Short-Chain Fatty Acid Production and Modulating Essential Adaptive Immune Pathways.
    Inflamm Bowel Dis. 2023 Jan 28:izac284. doi: 10.1093.
    PubMed     Abstract available


  368. PHAN H, Hayney MS, Caldera F
    Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".
    Inflamm Bowel Dis. 2023 Jan 28:izad006. doi: 10.1093.
    PubMed    


  369. GANTZEL RH, Vesterdal JD, Haase AM, Petersen AJ, et al
    The Prevalence of Inflammatory Bowel Disease in Greenland.
    Inflamm Bowel Dis. 2023 Jan 25:izad002. doi: 10.1093.
    PubMed     Abstract available


  370. YOKOSE S, Murono K, Nozawa H, Sasaki K, et al
    Preoperative Simulation of Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis Using a 3-Dimensional Printed Model.
    Inflamm Bowel Dis. 2023 Jan 23:izac283. doi: 10.1093.
    PubMed     Abstract available


  371. JEONG J, Walters TD, Huynh HQ, Lawrence S, et al
    Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent.
    Inflamm Bowel Dis. 2023 Jan 23:izac276. doi: 10.1093.
    PubMed     Abstract available


  372. BASSON AR, Katz J, Singh S, Celio F, et al
    Sweets and Inflammatory Bowel Disease: Patients Favor Artificial Sweeteners and Diet Foods/Drinks Over Table Sugar and Consume Less Fruits/Vegetables.
    Inflamm Bowel Dis. 2023 Jan 21:izac272. doi: 10.1093.
    PubMed     Abstract available


  373. FERRU-CLEMENT R, Boucher G, Forest A, Bouchard B, et al
    Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease.
    Inflamm Bowel Dis. 2023 Jan 20:izac281. doi: 10.1093.
    PubMed     Abstract available


  374. PANES J, Loftus EV, Higgins PDR, Lindsay JO, et al
    Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results.
    Inflamm Bowel Dis. 2023 Jan 16:izac260. doi: 10.1093.
    PubMed     Abstract available


  375. IKEDA A, Kunisaki R, Aoki S, Yaguchi K, et al
    Appropriate Preconception Corticosteroid-Free Remission Period in Pregnant Women With Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Jan 14:izac270. doi: 10.1093.
    PubMed     Abstract available


  376. GHIBOUB M, Boneh RS, Sovran B, Wine E, et al
    Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways.
    Inflamm Bowel Dis. 2023 Jan 13:izac262. doi: 10.1093.
    PubMed     Abstract available


  377. BARBERIO B, Gracie DJ, Black CJ, Ford AC, et al
    Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis.
    Inflamm Bowel Dis. 2023 Jan 13:izac263. doi: 10.1093.
    PubMed     Abstract available


  378. BOKEMEYER B, Plachta-Danielzik S, di Giuseppe R, Mohl W, et al
    Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
    Inflamm Bowel Dis. 2023 Jan 12:izac271. doi: 10.1093.
    PubMed     Abstract available


  379. LIN WC, Tai WC, Chang CH, Tu CH, et al
    Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
    Inflamm Bowel Dis. 2023 Jan 10:izac269. doi: 10.1093.
    PubMed     Abstract available


  380. YANG Y, Ludvigsson JF, Olen O, Sjolander A, et al
    Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based Study.
    Inflamm Bowel Dis. 2023 Jan 7:izac267. doi: 10.1093.
    PubMed     Abstract available


  381. FUENTES-VALENZUELA E, Garcia-Alonso FJ, Maroto-Martin C, Juan Casamayor L, et al
    Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2023 Jan 7:izac259. doi: 10.1093.
    PubMed     Abstract available


  382. KURDI AT, Noor NM, Gold SL
    IBD Journal Editorial Fellowship: A Practical Guide for Future Fellows.
    Inflamm Bowel Dis. 2023;29:172-173.
    PubMed    


  383. ROBBE MASSELOT C, Cordier C, Marsac B, Nachury M, et al
    Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023;29:167-171.
    PubMed    


  384. MANSKI SA, Schlachterman A
    Bypass of a Duodenal Stricture in Crohn's Disease Using a Lumen Opposing Metal Stent (LAMS): A Case Report.
    Inflamm Bowel Dis. 2023;29:177-178.
    PubMed    


  385. WEI S, Zhang J, Wu X, Chen M, et al
    Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis.
    Inflamm Bowel Dis. 2023;29:9-26.
    PubMed     Abstract available


  386. LIU Q, Wang D, Yang X, Ma F, et al
    The Mechanosensitive Ion Channel PIEZO1 in Intestinal Epithelial Cells Mediates Inflammation through the NOD-Like Receptor 3 Pathway in Crohn's Disease.
    Inflamm Bowel Dis. 2023;29:103-115.
    PubMed     Abstract available


  387. KHOSRAVI B, Salehnia A, Pak N, Montazeri SA, et al
    A Practical Index to Distinguish Backwash Ileitis From Crohn's Terminal Ileitis in MR Enterography.
    Inflamm Bowel Dis. 2023;29:42-50.
    PubMed     Abstract available


  388. CORRIDONI D, Pizarro TT
    Single-cell Transcriptomics Reveal the Importance of Distinct Epithelial Cell Populations in Ileal-specific, Treatment-naive, and Treated Crohn's Disease Patients.
    Inflamm Bowel Dis. 2023 Jan 4:izac264. doi: 10.1093.
    PubMed    


  389. PODDAR U, Aggarwal A, Jayalakshmi K, Sarma MS, et al
    Higher Prevalence of Monogenic Cause Among Very Early Onset Inflammatory Bowel Disease in Children: Experience From a Tertiary Care Center From Northern India.
    Inflamm Bowel Dis. 2023 Jan 3:izac254. doi: 10.1093.
    PubMed     Abstract available


    December 2022
  390. VALVANO M, Magistroni M, Cesaro N, Carlino G, et al
    Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2022 Dec 29:izac253. doi: 10.1093.
    PubMed     Abstract available


  391. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.
    Inflamm Bowel Dis. 2022 Dec 29:izac257. doi: 10.1093.
    PubMed    



  392. Correction to: The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Dec 28:izac258. doi: 10.1093.
    PubMed    


  393. DESAI A, Deepak P, Cross RK, Murone J, et al
    Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.
    Inflamm Bowel Dis. 2022 Dec 28:izac252. doi: 10.1093.
    PubMed     Abstract available


  394. TONG JKC, Mascuilli T, Wirtalla C, Aarons CB, et al
    Evaluating Changes in Surgical Outcomes for Patients With Inflammatory Bowel Disease Following Medicaid Expansion.
    Inflamm Bowel Dis. 2022 Dec 27:izac255. doi: 10.1093.
    PubMed     Abstract available


  395. ALFAIFI J, Germain A, Heba AC, Arnone D, et al
    Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Dec 21:izac250. doi: 10.1093.
    PubMed     Abstract available


  396. WANG J, Macoritto M, Guay H, Davis JW, et al
    The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-alpha Inadequate Response Mechanisms.
    Inflamm Bowel Dis. 2022 Dec 14:izac246. doi: 10.1093.
    PubMed     Abstract available


  397. POKROTNIEKS J, Sitkin S
    Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma.
    Inflamm Bowel Dis. 2022 Dec 14:izac248. doi: 10.1093.
    PubMed    


  398. SHIH T, Yusung S, Gonsky R, Dutra-Clarke R, et al
    Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location.
    Inflamm Bowel Dis. 2022 Dec 12:izac251. doi: 10.1093.
    PubMed    


  399. BOMMENA S, Goldberg A, Amini M, Alishahi Y, et al
    Depression in Women With Inflammatory Bowel Disease: A Multifaceted Approach for a Multidimensional Problem.
    Inflamm Bowel Dis. 2022 Dec 6:izac245. doi: 10.1093.
    PubMed     Abstract available


  400. SALVATORI S, Marafini I, Venuto C, Laudisi F, et al
    Frail Phenotype in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Dec 2:izac242. doi: 10.1093.
    PubMed     Abstract available


  401. ABREU MT, Davies JM, Quintero MA, Delmas A, et al
    Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
    Inflamm Bowel Dis. 2022;28:1800-1812.
    PubMed     Abstract available


  402. MORGAN NN, Duck LW, Wu J, Rujani M, et al
    Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
    Inflamm Bowel Dis. 2022;28:1893-1903.
    PubMed     Abstract available


  403. HONG SJ, Zenger C, Pecoriello J, Pang A, et al
    Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy.
    Inflamm Bowel Dis. 2022;28:1826-1832.
    PubMed     Abstract available


  404. DAWSON R, Wands DIF, Logan M, Bremner G, et al
    Comparing Effectiveness of a Generic Oral Nutritional Supplement With Specialized Formula in the Treatment of Active Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1859-1864.
    PubMed     Abstract available


  405. PAN Y, Ahmed W, Mahtani P, Wong R, et al
    Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1865-1871.
    PubMed     Abstract available


  406. BROWN SC, Whelan K, Frampton C, Wall CL, et al
    Food-Related Quality of Life in Children and Adolescents With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1838-1843.
    PubMed     Abstract available


  407. SASIDHARAN S, Sasson AN, Shannon KM, Ananthakrishnan AN, et al
    Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis.
    Inflamm Bowel Dis. 2022;28:1833-1837.
    PubMed     Abstract available


    November 2022
  408. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 25:izac231. doi: 10.1093.
    PubMed     Abstract available


  409. CHEN K, Chen J, Smith E, Mathani P, et al
    Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 24:izac236. doi: 10.1093.
    PubMed    


  410. COLMAN RJ, Samuels A, Mizuno T, Punt N, et al
    Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 22:izac237. doi: 10.1093.
    PubMed    



  411. Correction to: Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 18. pii: 6832530. doi: 10.1093.
    PubMed    


  412. POLAT G, Kani HT, Ergenc I, Ozen Alahdab Y, et al
    Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning.
    Inflamm Bowel Dis. 2022 Nov 16. pii: 6830946. doi: 10.1093.
    PubMed     Abstract available


  413. YOGEV D, Verstockt B, Dignass A, Focht G, et al
    The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease.
    Inflamm Bowel Dis. 2022 Nov 9:izac235. doi: 10.1093.
    PubMed    


  414. LICHTENSTEIN GR, Bressler B, Francisconi C, Vermeire S, et al
    Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Nov 7. pii: 6808367. doi: 10.1093.
    PubMed     Abstract available


  415. SHIMOYAMA T, Yamamoto T, Yoshiyama S, Nishikawa R, et al
    Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 5. pii: 6804445. doi: 10.1093.
    PubMed     Abstract available


  416. RAMOS L, Hernandez-Porto M, Carrillo-Palau M, Alonso-Abreu I, et al
    Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2022 Nov 2. pii: 6793895. doi: 10.1093.
    PubMed    


  417. SCHWEDA A, Becker E, Wiendl M, Atreya R, et al
    Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells.
    Inflamm Bowel Dis. 2022;28:1746-1755.
    PubMed     Abstract available


  418. DALAL RS, Bains K, Marcus J, McClure EL, et al
    Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series.
    Inflamm Bowel Dis. 2022;28:1787-1789.
    PubMed    


  419. KREISS L, Thoma OM, Lemire S, Lechner K, et al
    Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging.
    Inflamm Bowel Dis. 2022;28:1637-1646.
    PubMed     Abstract available


  420. XU L, Huang G, Cong Y, Yu Y, et al
    Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones.
    Inflamm Bowel Dis. 2022;28:1766-1775.
    PubMed     Abstract available


  421. MAHMUD N, Shah Y, Khan N
    Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients.
    Inflamm Bowel Dis. 2022;28:1776-1780.
    PubMed    


  422. CHAPARRO M, Baston-Rey I, Fernandez-Salgado E, Gonzalez Garcia J, et al
    Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
    Inflamm Bowel Dis. 2022;28:1725-1736.
    PubMed     Abstract available


  423. ATTAUABI M, Wewer MD, Bendtsen F, Seidelin JB, et al
    Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2022;28:1756-1765.
    PubMed     Abstract available


  424. PANES J, Bouma G, Ferrante M, Kucharzik T, et al
    INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
    Inflamm Bowel Dis. 2022;28:1737-1745.
    PubMed     Abstract available


  425. LIMKETKAI BN, Hamideh M, Shah R, Sauk JS, et al
    Dietary Patterns and Their Association With Symptoms Activity in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:1627-1636.
    PubMed     Abstract available


  426. INOUE A, Bartlett DJ, Shahraki N, Sheedy SP, et al
    Predicting Risk of Surgery in Patients With Small Bowel Crohn's Disease Strictures Using Computed Tomography and Magnetic Resonance Enterography.
    Inflamm Bowel Dis. 2022;28:1677-1686.
    PubMed     Abstract available


  427. SAVELKOUL EHJ, Thomas PWA, Derikx LAAP, den Broeder N, et al
    Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Nov 1. pii: 6786024. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  428. BOYD T, Friedman S
    Challenges and Opportunities for Advancing Research and Improving Care for Sexual and Gender Minorities With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Oct 29. pii: 6779855. doi: 10.1093.
    PubMed    


  429. GOLD SL, Manning L, Kohler D, Ungaro R, et al
    Micronutrients and Their Role in Inflammatory Bowel Disease: Function, Assessment, Supplementation, and Impact on Clinical Outcomes Including Muscle Health.
    Inflamm Bowel Dis. 2022 Oct 26. pii: 6774890. doi: 10.1093.
    PubMed    


  430. SCOTT FI, Ehrlich O, Wood D, Viator C, et al
    Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.
    Inflamm Bowel Dis. 2022 Oct 22. pii: 6769932. doi: 10.1093.
    PubMed     Abstract available


  431. AHMED W, Billing W, Stump TE, Strobel T, et al
    Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022 Oct 22. pii: 6769933. doi: 10.1093.
    PubMed     Abstract available


  432. BIEDERMANN L, Dubinsky MC, Vermeire S, Fellmann M, et al
    Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
    Inflamm Bowel Dis. 2022 Oct 15. pii: 6761656. doi: 10.1093.
    PubMed     Abstract available


  433. BREUGELMANS T, Arras W, Boen LE, Borms E, et al
    Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity.
    Inflamm Bowel Dis. 2022 Oct 14. pii: 6761121. doi: 10.1093.
    PubMed     Abstract available


  434. LUTZ M, Hayney MS, Farraye FA, Caldera F, et al
    A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Oct 6. pii: 6749562. doi: 10.1093.
    PubMed    


  435. JORDI SBU, Begre S, Misselwitz B
    Should a Psychologist Be a Mandatory Component of IBD Consults? Yes-Authors' Reply.
    Inflamm Bowel Dis. 2022;28:e138-e139.
    PubMed    


  436. CHEN HM, MacDonald JA
    Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
    Inflamm Bowel Dis. 2022;28:1485-1496.
    PubMed     Abstract available


  437. ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
    Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study.
    Inflamm Bowel Dis. 2022;28:1618-1622.
    PubMed    


  438. LUPU G, Weaver KN, Herfarth HH, Barnes EL, et al
    Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2022;28:1610-1613.
    PubMed    


  439. SANTIAGO M, Dias CC, Alves C, Ministro P, et al
    The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review.
    Inflamm Bowel Dis. 2022;28:1527-1536.
    PubMed     Abstract available


  440. ADLER J, Eder SJ, Gebremariam A, Moran CJ, et al
    Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1537-1542.
    PubMed     Abstract available


  441. TSAI L, McCurdy JD, Ma C, Jairath V, et al
    Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.
    Inflamm Bowel Dis. 2022;28:1477-1484.
    PubMed     Abstract available


    September 2022
  442. VUYYURU SK, Brahmania M, Arab JP, Jairath V, et al
    Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy.
    Inflamm Bowel Dis. 2022 Sep 29. pii: 6731264. doi: 10.1093.
    PubMed    


  443. SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
    Reply to "Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy".
    Inflamm Bowel Dis. 2022 Sep 29. pii: 6731245. doi: 10.1093.
    PubMed    


  444. TANNER S, Katz J, Cominelli F, Regueiro M, et al
    Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?
    Inflamm Bowel Dis. 2022 Sep 28. pii: 6726164. doi: 10.1093.
    PubMed    


  445. MULES TC, Swaminathan A, Hirschfeld E, Borichevsky GM, et al
    The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Sep 27. pii: 6724308. doi: 10.1093.
    PubMed     Abstract available


  446. TANAKA M, Kawakami A, Sakagami K, Terai T, et al
    Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.
    Inflamm Bowel Dis. 2022 Sep 27. pii: 6723730. doi: 10.1093.
    PubMed     Abstract available


  447. VAN WASSENAER EA, van Rijn RR, Zwetsloot SLM, de Voogd FAE, et al
    Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices.
    Inflamm Bowel Dis. 2022 Sep 23. pii: 6712311. doi: 10.1093.
    PubMed     Abstract available


  448. BAKHSHI Z, Yadav S, Harmsen WS, Edakkanambeth Varayil J, et al
    Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes.
    Inflamm Bowel Dis. 2022 Sep 23. pii: 6712289. doi: 10.1093.
    PubMed     Abstract available


  449. CHOI B, Sey M, Ponich T, Beaton M, et al
    Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype.
    Inflamm Bowel Dis. 2022 Sep 16. pii: 6702271. doi: 10.1093.
    PubMed     Abstract available


  450. ABDEL-RAHMAN LIH, Morgan XC
    Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis.
    Inflamm Bowel Dis. 2022 Sep 16. pii: 6702269. doi: 10.1093.
    PubMed     Abstract available


  451. CALDERA F, Farraye FA, Necela BM, Cogen D, et al
    Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
    Inflamm Bowel Dis. 2022 Sep 14. pii: 6697965. doi: 10.1093.
    PubMed     Abstract available


  452. MACEDO SILVA V, Lima Capela T, Freitas M, Curdia Goncalves T, et al
    Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
    Inflamm Bowel Dis. 2022 Sep 13. pii: 6696695. doi: 10.1093.
    PubMed     Abstract available


  453. CROUWEL F, Simsek M, van Doorn AS, Mulder CJJ, et al
    Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.
    Inflamm Bowel Dis. 2022 Sep 13. pii: 6696694. doi: 10.1093.
    PubMed    


  454. NARKIS B, Hadar E, Barbash-Hazan S, Houri O, et al
    Peripartum Infections Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Sep 1. pii: 6682832. doi: 10.1093.
    PubMed     Abstract available


  455. MARION L, Amelie B, Zoubir D, Guillaume C, et al
    Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
    Inflamm Bowel Dis. 2022;28:1395-1404.
    PubMed     Abstract available


  456. HANZEL J, Sedano R, Jeyarajah J, Zou G, et al
    Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression.
    Inflamm Bowel Dis. 2022;28:1462-1464.
    PubMed    


  457. CARTER D, Ben-Horin S, Horesh N, Saukhat O, et al
    Ultrasound-Tomographic Image Fusion: A Novel Imaging Technique for Follow-Up of Penetrating Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1451-1453.
    PubMed     Abstract available


  458. PICORARO JA, Shen B
    The Pediatric Pouch Deserves Precision.
    Inflamm Bowel Dis. 2022;28:1469-1471.
    PubMed    


  459. DUBINSKY MC, Mendiolaza ML, Phan BL, Moran HR, et al
    Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.
    Inflamm Bowel Dis. 2022;28:1375-1385.
    PubMed     Abstract available


  460. CHIN KOON SIW K, Engel J, Visva S, Mallick R, et al
    Strategies to Distinguish Perianal Fistulas Related to Crohn's Disease From Cryptoglandular Disease: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2022;28:1363-1374.
    PubMed     Abstract available


  461. HANZEL J, Jairath V, De Cruz P, Guizzetti L, et al
    Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1321-1331.
    PubMed     Abstract available


    August 2022
  462. HOYHTYA M, Korpela K, Saqib S, Junkkari S, et al
    Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 30. pii: 6679143. doi: 10.1093.
    PubMed     Abstract available


  463. VAUGHAN R, Murphy E, Nalder M, Gibson RN, et al
    Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 27. pii: 6696163. doi: 10.1093.
    PubMed     Abstract available


  464. WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
    The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Aug 26. pii: 6677128. doi: 10.1093.
    PubMed    


  465. ALENEZY N, Nugent Z, Herman S, Zaborniak K, et al
    Aeroallergen-related Diseases Predate the Diagnosis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 26. pii: 6677127. doi: 10.1093.
    PubMed     Abstract available


  466. DAI C, Huang YH
    The Role of Appendicectomy in Ulcerative Colitis: True or Coincidental Association?
    Inflamm Bowel Dis. 2022 Aug 24. pii: 6674531. doi: 10.1093.
    PubMed    


  467. YU N, Basnayake C
    Vaccinations for Patients With Inflammatory Bowel Disease in Primary Care: An Opportunity for Improvement.
    Inflamm Bowel Dis. 2022 Aug 23. pii: 6674008. doi: 10.1093.
    PubMed    


  468. LI D, Debbas P, Mujukian A, Cheng S, et al
    Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD.
    Inflamm Bowel Dis. 2022 Aug 23. pii: 6673996. doi: 10.1093.
    PubMed     Abstract available


  469. KIM C, Yin Z, Kamdar N, Stidham R, et al
    Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children.
    Inflamm Bowel Dis. 2022 Aug 20. pii: 6672842. doi: 10.1093.
    PubMed     Abstract available


  470. ODUFALU FD
    Editorial: Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 20. pii: 6672843. doi: 10.1093.
    PubMed    


  471. HELLMANN J, Ta A, Ollberding NJ, Bezold R, et al
    Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 16. pii: 6668484. doi: 10.1093.
    PubMed     Abstract available


  472. KUMAR S, Pollok R, Goldsmith D
    Renal and Urological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 9. pii: 6658535. doi: 10.1093.
    PubMed     Abstract available


  473. ALOI M, D'Arcangelo G, Rossetti D, Bucherini S, et al
    Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Aug 9. pii: 6658537. doi: 10.1093.
    PubMed     Abstract available


  474. NAROUS M, Nugent Z, Singh H, Bernstein CN, et al
    Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
    Inflamm Bowel Dis. 2022 Aug 5. pii: 6656176. doi: 10.1093.
    PubMed     Abstract available


  475. YANG JY, Lund JL, Pate V, Kappelman MD, et al
    Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019.
    Inflamm Bowel Dis. 2022 Aug 5. pii: 6656175. doi: 10.1093.
    PubMed     Abstract available


  476. SOOD A, Singh A, Mahajan R, Midha V, et al
    (Re)Appraising Remission in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 2. pii: 6653351. doi: 10.1093.
    PubMed     Abstract available


  477. GREYWOODE R, Petralia F, Ullman TA, Frederic Colombel J, et al
    Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Aug 1. pii: 6652811. doi: 10.1093.
    PubMed     Abstract available


  478. LIBERTUCCI J, Dutta U, Armstrong D
    Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2022;28:e120.
    PubMed    


  479. OLAISEN M, Fossmark R
    Reply to "Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients".
    Inflamm Bowel Dis. 2022;28:e121.
    PubMed    


  480. BICKSTON SJ, Patrone MV
    Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:1296-1297.
    PubMed    


  481. BLAISDELL A, Zhou Y, Kattah MG, Fisher SJ, et al
    Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
    Inflamm Bowel Dis. 2022;28:1219-1228.
    PubMed     Abstract available


  482. HE S, Azar DA, Esfahani FN, Azar GA, et al
    Mechanoscopy: A Novel Device and Procedure for in vivo Detection of Chronic Colitis in Mice.
    Inflamm Bowel Dis. 2022;28:1143-1150.
    PubMed     Abstract available


  483. DAHAR MM, Ramos Rivers C, Ahsan M, Johnston E, et al
    Positive Gluten Sensitivity Serologies and the Impact of Gluten-free Diet in Patients With IBD.
    Inflamm Bowel Dis. 2022;28:e122-e123.
    PubMed    


  484. MOENS A, Verstockt B, Alsoud D, Sabino J, et al
    Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.
    Inflamm Bowel Dis. 2022;28:1135-1142.
    PubMed     Abstract available


  485. ROBLIN X, Serone A, Yoon OK, Zhuo L, et al
    Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1207-1218.
    PubMed     Abstract available


  486. EVERHOV AH, Kalman TD, Soderling J, Nordenvall C, et al
    Probability of Stoma in Incident Patients With Crohn's Disease in Sweden 2003-2019: A Population-based Study.
    Inflamm Bowel Dis. 2022;28:1160-1168.
    PubMed     Abstract available


  487. NOOR NM, Sousa P, Paul S, Roblin X, et al
    Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.
    Inflamm Bowel Dis. 2022;28:1254-1264.
    PubMed     Abstract available


    July 2022
  488. TAFT TH, McGarva J, Omprakash TA, Tomasino K, et al
    Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
    Inflamm Bowel Dis. 2022 Jul 27. pii: 6650637. doi: 10.1093.
    PubMed     Abstract available


  489. GLYNN H, Mikocka-Walus A, Knowles SR
    Editorial: Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
    Inflamm Bowel Dis. 2022 Jul 27. pii: 6650636. doi: 10.1093.
    PubMed    


  490. GRANT RK, Brindle WM, Arnott IDR
    The Value of a Dedicated IBD Flare Clinic to Effectively Manage Exacerbations of Inflammatory Bowel Disease: The Edinburgh IBD Unit.
    Inflamm Bowel Dis. 2022 Jul 22. pii: 6648508. doi: 10.1093.
    PubMed    


  491. HSU C, Ghannoum M, Cominelli F, Martino LD, et al
    Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies.
    Inflamm Bowel Dis. 2022 Jul 19. pii: 6646155. doi: 10.1093.
    PubMed     Abstract available



  492. Correction to: Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 Jul 18. pii: 6645873. doi: 10.1093.
    PubMed    


  493. CROSBY S, Schuh MJ, Becker M, Ivanov M, et al
    New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 13. pii: 6643251. doi: 10.1093.
    PubMed     Abstract available


  494. WEAVER KN, Zhang X, Dai X, Chen W, et al
    Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 13. pii: 6643250. doi: 10.1093.
    PubMed    


  495. LIU JJ, Abraham BP, Adamson P, Barnes EL, et al
    The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2022 Jul 11. pii: 6639794. doi: 10.1093.
    PubMed     Abstract available


  496. BUISSON A, Serrero M, Orsat L, Nancey S, et al
    Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
    Inflamm Bowel Dis. 2022 Jul 11. pii: 6639655. doi: 10.1093.
    PubMed     Abstract available


  497. SHARMA N
    Should a Psychologist Be a Mandatory Component of Inflammatory Bowel Disease Consults? Yes.
    Inflamm Bowel Dis. 2022 Jul 6. pii: 6632462. doi: 10.1093.
    PubMed    


  498. LOFTUS EV, Baumgart DC, Gecse K, Kinnucan JA, et al
    Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.
    Inflamm Bowel Dis. 2022 Jul 6. pii: 6632473. doi: 10.1093.
    PubMed     Abstract available


  499. YUAN W, Marwaha JS, Rakowsky ST, Palmer NP, et al
    Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
    Inflamm Bowel Dis. 2022 Jul 4. pii: 6628670. doi: 10.1093.
    PubMed     Abstract available


  500. XU F, deJong N, Kappelman MD, Greenlund KJ, et al
    Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jul 2. pii: 6627525. doi: 10.1093.
    PubMed     Abstract available


  501. SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
    Alterations in the Course of Inflammatory Bowel Disease Following Liver Transplantation: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2022 Jul 2. pii: 6627524. doi: 10.1093.
    PubMed     Abstract available


  502. HOLMGREN J, Froborg A, Visuri I, Halfvarson J, et al
    The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022 Jul 1. pii: 6625867. doi: 10.1093.
    PubMed     Abstract available


  503. GONZALEZ-BERNARDO O, Riestra S
    Reply to "Virtual Chromoendoscopy vs High-definition White Light Endoscopy Using iSCAN".
    Inflamm Bowel Dis. 2022;28:e107.
    PubMed    


  504. JURICKOVA I, Bonkowski E, Angerman E, Novak E, et al
    Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2022;28:988-1003.
    PubMed     Abstract available


  505. WEAVER KN, Herfarth HH, Barnes EL
    Antibiotic Use Patterns in the Management of Chronic Pouchitis.
    Inflamm Bowel Dis. 2022;28:e92-e93.
    PubMed    


  506. CAO X, Yuan H, Liang J, Huang H, et al
    Elective Switching on Biosimilars: Far More Than Nonmedical Switching.
    Inflamm Bowel Dis. 2022;28:e101-e102.
    PubMed    


  507. KAYAL M, Plietz M, Wang YHW, Khaitov S, et al
    Crohn's Disease Like Pouch Inflammation Is Associated With Decreased Odds of Secondary Ileostomy Closure After Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022;28:1123-1125.
    PubMed    


  508. BAR N, Avraham Y, Dubinsky V, Cohen NA, et al
    Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
    Inflamm Bowel Dis. 2022;28:1027-1033.
    PubMed     Abstract available


  509. WIJNANDS AM, Te Groen M, Peters Y, Kaptein AA, et al
    Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
    Inflamm Bowel Dis. 2022;28:1053-1060.
    PubMed     Abstract available


  510. D'HAENS GR, Reinisch W, Lee SD, Tarabar D, et al
    Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study.
    Inflamm Bowel Dis. 2022;28:1034-1044.
    PubMed     Abstract available


    June 2022
  511. CLAXTON BB, Sun G, Nahar R, Henry C, et al
    Myocardial Infarction With Nonobstructive Coronary Arteries in New-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jun 30. pii: 6623438. doi: 10.1093.
    PubMed    


  512. HARLAN NP, Roberts J, Siegel C, Buckey JC, et al
    Hyperbaric Oxygen as Successful Monotherapy for a Severe Ulcerative Colitis Flare.
    Inflamm Bowel Dis. 2022 Jun 30. pii: 6623436. doi: 10.1093.
    PubMed    


  513. EL HAGE CHEHADE N, Ghoneim S, Shah S, Chahine A, et al
    Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
    Inflamm Bowel Dis. 2022 Jun 29. pii: 6619552. doi: 10.1093.
    PubMed     Abstract available


  514. WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
    The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Jun 29. pii: 6619547. doi: 10.1093.
    PubMed     Abstract available


  515. PREZIOSI NA, Rizvi AH, Feerick JD, Mandelia C, et al
    De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters.
    Inflamm Bowel Dis. 2022 Jun 28. pii: 6619087. doi: 10.1093.
    PubMed    


  516. SEDANO R, Hogan M, Zou G, Narula N, et al
    Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617565. doi: 10.1093.
    PubMed    


  517. INNOCENTI T, Bigagli E, Lynch EN, Galli A, et al
    MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617564. doi: 10.1093.
    PubMed     Abstract available


  518. ARJOMAND FARD N, Armstrong H, Perry T, Wine E, et al
    Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617562. doi: 10.1093.
    PubMed     Abstract available


  519. LIU E, Laube R, Leong RW, Fraser A, et al
    Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making.
    Inflamm Bowel Dis. 2022 Jun 17. pii: 6609865. doi: 10.1093.
    PubMed     Abstract available


  520. JORDAN A, Maraj B, Kinnucan J
    Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608386. doi: 10.1093.
    PubMed    


  521. LONG MD, Afzali A, Fischer M, Hudesman D, et al
    Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608417. doi: 10.1093.
    PubMed     Abstract available


  522. KAWAMOTO A, Fujii T, Mitani R, Suzuki Y, et al
    Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608379. doi: 10.1093.
    PubMed    


  523. STAFFORD IS, Gosink MM, Mossotto E, Ennis S, et al
    A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608231. doi: 10.1093.
    PubMed     Abstract available


  524. TIAN WN, Huang YH, Dai C
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.
    Inflamm Bowel Dis. 2022 Jun 6. pii: 6603234. doi: 10.1093.
    PubMed    


  525. JEDEL S, Beck T, Swanson G, Hood MM, et al
    Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial.
    Inflamm Bowel Dis. 2022 Jun 4. pii: 6602039. doi: 10.1093.
    PubMed     Abstract available


  526. TURSI A, Nenna R
    COVID-19 as a Trigger for De Novo Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e76-e77.
    PubMed    


  527. ZHANG Y, Tian F, Li H
    Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn's Disease Treated With Infliximab.
    Inflamm Bowel Dis. 2022;28:e80-e81.
    PubMed    


  528. STIDHAM RW, Yu D, Zhao X, Bishu S, et al
    Identifying the Presence, Activity, and Status of Extraintestinal Manifestations of Inflammatory Bowel Disease Using Natural Language Processing of Clinical Notes.
    Inflamm Bowel Dis. 2022 Jun 3. pii: 6601382. doi: 10.1093.
    PubMed     Abstract available


  529. YU M, Zhu W, Wang J, Chen X, et al
    Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
    Inflamm Bowel Dis. 2022;28:923-935.
    PubMed     Abstract available


  530. WANG B, Li R, Zhang S, Zhao Q, et al
    A Case of Behcet's Disease With Hepatic Lesions Misdiagnosed as Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e86-e87.
    PubMed    


  531. DONG G, Yang Y, Zhang H, Yu W, et al
    Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC.
    Inflamm Bowel Dis. 2022;28:830-842.
    PubMed     Abstract available


  532. WANG X, Tang J, Zheng JW, Huang WF, et al
    Granulomatous Pneumonia and Liver Lesions Associated With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e78-e79.
    PubMed    


  533. SORENSEN KM, Jensen CH, Sheikh SP, Qvist N, et al
    Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.
    Inflamm Bowel Dis. 2022;28:967-970.
    PubMed    


  534. FRADKOV E, Sheehan J, Cushing K, Higgins PDR, et al
    Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease.
    Inflamm Bowel Dis. 2022;28:895-904.
    PubMed     Abstract available


  535. CHEN G, Pedarla V, Null KD, Cazzetta SE, et al
    Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
    Inflamm Bowel Dis. 2022;28:870-877.
    PubMed     Abstract available


  536. JAVAID A, Shahab O, Adorno W, Fernandes P, et al
    Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:819-829.
    PubMed     Abstract available


  537. NOORIAN S, Jeon Y, Nguyen MT, Sauk J, et al
    The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Inflamm Bowel Dis. 2022;28:878-887.
    PubMed     Abstract available


  538. WITGES K, Sexton K, Graff LA, Targownik LE, et al
    What Is a Flare? The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2022;28:862-869.
    PubMed     Abstract available


  539. BROMS G
    IBD in the Postpartum Period: Spotlight on Maternal Outcomes.
    Inflamm Bowel Dis. 2022;28:980-981.
    PubMed    


  540. ABOUBAKR A, Gottlieb ZS, Riggs AR, Johnson SO, et al
    Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD.
    Inflamm Bowel Dis. 2022;28:843-849.
    PubMed     Abstract available


  541. RANGEL PANIZ G, Lebow J, Sim L, Lacy BE, et al
    Eating Disorders: Diagnosis and Management Considerations for the IBD Practice.
    Inflamm Bowel Dis. 2022;28:936-946.
    PubMed    


  542. CAO Q, Chen C, Gao X, Chen Y, et al
    Real-world Short-term Effectiveness of Ustekinumab in Crohn's Disease: Results from a Multicenter, Prospective Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed    


  543. PENG L, Hu S, Yu Q, Chen Y, et al
    Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  544. CHEN YJ, Chen BL, Liang MJ, Chen SL, et al
    Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn's Disease: A Pilot Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  545. ARKENBOSCH JHC, Mak JWY, Ho JCL, Beelen EMJ, et al
    Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  546. YAO L, Chen H, Shao B, Liu J, et al
    Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  547. BAI X, Zhang H, Ruan G, Lv H, et al
    Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn's Disease in China: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  548. WINTHROP KL, Vermeire S, Long MD, Panes J, et al
    Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2022 Jun 1. pii: 6596831. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  549. TSE CS, Melmed GY, Siegel CA, Weng CH, et al
    Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594471. doi: 10.1093.
    PubMed    


  550. WINTER RW, Boyd T, Chan WW, Levy AN, et al
    Risk Factors for Voluntary Childlessness in Men and Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594473. doi: 10.1093.
    PubMed    


  551. WU S, Xie S, Yuan C, Yang Z, et al
    Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
    Inflamm Bowel Dis. 2022 May 27. pii: 6594105. doi: 10.1093.
    PubMed     Abstract available


  552. SOOKAROMDEE P, Wiwanitkit V
    Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022 May 27. pii: 6594100. doi: 10.1093.
    PubMed    


  553. GOLD SL, Rabinowitz LG, Manning L, Keefer L, et al
    High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589577. doi: 10.1093.
    PubMed     Abstract available


  554. GOODYEAR BG, Heidari F, Ingram RJM, Cortese F, et al
    Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589553. doi: 10.1093.
    PubMed     Abstract available


  555. SLEUTJES JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC, et al
    Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589576. doi: 10.1093.
    PubMed     Abstract available


  556. KAWASHIMA K, Oshima N, Kishimoto K, Kataoka M, et al
    Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2022 May 18. pii: 6588003. doi: 10.1093.
    PubMed     Abstract available


  557. MADSEN GR, Bertl K, Pandis N, Stavropoulos A, et al
    The Impact of Periodontitis on Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2022 May 12. pii: 6584926. doi: 10.1093.
    PubMed     Abstract available


  558. DE KRIJGER M, Carvalho B, Rausch C, Bolijn AS, et al
    Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584483. doi: 10.1093.
    PubMed     Abstract available


  559. RIZVI A, Trivedi P, Bar-Mashiah A, Plietz M, et al
    Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584485. doi: 10.1093.
    PubMed    


  560. DE SIRE R, Rispo A, Compare D, Tortora F, et al
    Wernicke Encephalopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022;28:e70-e71.
    PubMed    


  561. BATTAT R
    Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e61.
    PubMed    


  562. MC GETTIGAN N, Boland K, O'Toole A
    Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e59-e60.
    PubMed    


  563. PEREZ K, Ngollo M, Rabinowitz K, Hammoudi N, et al
    Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
    Inflamm Bowel Dis. 2022;28:775-782.
    PubMed     Abstract available


  564. ETWEBI Z, Goldsmith JR, Bou-Dargham M, Tian Y, et al
    TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
    Inflamm Bowel Dis. 2022;28:764-774.
    PubMed     Abstract available


  565. NIGAM GB, Patel RN, Lakhtakia S, Desai D, et al
    A Survey of Endoscopists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India.
    Inflamm Bowel Dis. 2022;28:e64-e65.
    PubMed    


  566. GOLUSDA L, Kuhl AA, Siegmund B, Paclik D, et al
    Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response.
    Inflamm Bowel Dis. 2022;28:801-807.
    PubMed     Abstract available


  567. ZHAO QF, Wang S
    Crohn's Disease Complicated by an Ileo-urachal Fistula.
    Inflamm Bowel Dis. 2022;28:e62-e63.
    PubMed    


  568. HUANG JS, Definis M, Cruz R, Parker J, et al
    Patient Portal Usage: An Objective Target for Transition Interventions Among Youth with IBD?
    Inflamm Bowel Dis. 2022;28:808-810.
    PubMed    


  569. ROBLIN X, Genin C, Nancey S, Williet N, et al
    Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
    Inflamm Bowel Dis. 2022;28:720-727.
    PubMed     Abstract available


  570. GU P, Chhabra A, Chittajallu P, Chang C, et al
    Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Inflamm Bowel Dis. 2022;28:657-666.
    PubMed     Abstract available


  571. BRENNER EJ, Long MD, Mann CM, Lin L, et al
    Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity.
    Inflamm Bowel Dis. 2022;28:728-733.
    PubMed     Abstract available


  572. DE CRUZ P, Hamilton AL, Burrell KJ, Gorelik A, et al
    Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
    Inflamm Bowel Dis. 2022;28:680-688.
    PubMed     Abstract available


    April 2022
  573. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 30. pii: 6576383. doi: 10.1093.
    PubMed    


  574. NELSON AD, Elkins JR, Stocchi L, Farraye FA, et al
    Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574514. doi: 10.1093.
    PubMed     Abstract available


  575. TORTORA C, Di Paola A, Creoli M, Argenziano M, et al
    Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574513. doi: 10.1093.
    PubMed     Abstract available


  576. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Increased Risk of Postpartum Infections After Caesarian and Vaginal Delivery in Women With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574515. doi: 10.1093.
    PubMed     Abstract available


  577. KWON JY, Daoud ND, Hashash JG, Picco MF, et al
    Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 25. pii: 6573907. doi: 10.1093.
    PubMed     Abstract available


  578. VELOSO FT
    Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573214. doi: 10.1093.
    PubMed    


  579. HASAN B, Ur Rahman A
    Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub.
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573283. doi: 10.1093.
    PubMed    


  580. MAO R, Ng SC, Chen M
    Network Clinical Collaboration to Improve Quality of Care of Patients with Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2022 Apr 20. pii: 6571486. doi: 10.1093.
    PubMed    


  581. MIKOLAJCZYK AE, Cohen NA, Watson S, Ackerman M, et al
    Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 18. pii: 6569959. doi: 10.1093.
    PubMed     Abstract available


  582. ZIV Y, Swaminath A, Sultan K
    Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical.
    Inflamm Bowel Dis. 2022 Apr 13. pii: 6568039. doi: 10.1093.
    PubMed    


  583. LI D, Xu A, Mengesha E, Elyanow R, et al
    The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565880. doi: 10.1093.
    PubMed    


  584. SEONG G, Song JH, Kim JE, Kim TJ, et al
    Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565877. doi: 10.1093.
    PubMed     Abstract available


  585. SCHELL TL, Knutson KL, Saha S, Wald A, et al
    Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565876. doi: 10.1093.
    PubMed    


  586. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565439. doi: 10.1093.
    PubMed    


  587. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565438. doi: 10.1093.
    PubMed    


  588. VALENTIN S, Renel B, Manneville F, Caron B, et al
    Prevalence of and Factors Associated with Respiratory Symptoms Among Patients with Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565436. doi: 10.1093.
    PubMed     Abstract available


  589. MACALUSO FS, Giuliano A, Fries W, Viola A, et al
    Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Inflamm Bowel Dis. 2022 Apr 6. pii: 6564282. doi: 10.1093.
    PubMed     Abstract available


  590. KUANG R, O'Keefe SJD, Ramos Del Aguila de Rivers C, Koutroumpakis F, et al
    Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563753. doi: 10.1093.
    PubMed     Abstract available


  591. DUBINSKY MC, Magro F, Steinwurz F, Hudesman DP, et al
    Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563756. doi: 10.1093.
    PubMed     Abstract available


  592. AGRAWAL M, Petralia F, Tepler A, Durbin L, et al
    Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562696. doi: 10.1093.
    PubMed     Abstract available


  593. BERGAMASCHI G, Castiglione F, D'Inca R, Astegiano M, et al
    Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562695. doi: 10.1093.
    PubMed     Abstract available


  594. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562694. doi: 10.1093.
    PubMed    


  595. FAYE AS, Dodson JA, Shaukat A
    Sarcopenia as a Risk Prediction Tool in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562699. doi: 10.1093.
    PubMed    


    March 2022
  596. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Response to the Letter to the Editor: "Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease".
    Inflamm Bowel Dis. 2022 Mar 31. pii: 6561784. doi: 10.1093.
    PubMed    


  597. PATIL SA, Bhat S, Limdi JK, Farraye FA, et al
    The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 30. pii: 6556005. doi: 10.1093.
    PubMed    


  598. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:e45.
    PubMed    


  599. COSTANTINO A, Noviello D, Costantino C, Vecchi M, et al
    Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".
    Inflamm Bowel Dis. 2022;28:e57-e58.
    PubMed    


  600. SCHRODER AL, Chami B, Liu Y, Doyle CM, et al
    Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:586-598.
    PubMed     Abstract available


  601. CHANDRASEKHARAN B, Boyer D, Owens JA, Wolfarth AA, et al
    Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.
    Inflamm Bowel Dis. 2022;28:502-513.
    PubMed     Abstract available


  602. LIGHTNER AL, Buhulaigah H, Zaghiyan K, Holubar SD, et al
    Is Intestinal Diversion an Effective Treatment for Distal Crohn's Disease?
    Inflamm Bowel Dis. 2022;28:547-552.
    PubMed     Abstract available


  603. LAWRENCE LS, Heider A, Singer AAM, Neef HC, et al
    Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn's Complications-But May Be Preventable.
    Inflamm Bowel Dis. 2022;28:523-530.
    PubMed     Abstract available


  604. GANDHI S, Zelman S, De Armas RE, Hemond C, et al
    Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis.
    Inflamm Bowel Dis. 2022 Mar 26. pii: 6554576. doi: 10.1093.
    PubMed    


  605. DASHARATHY SS, Long MD, Lackner JM, Ben-Ami Shor D, et al
    Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553867. doi: 10.1093.
    PubMed     Abstract available


  606. GREYWOODE R, Ullman T, Keefer L
    National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553591. doi: 10.1093.
    PubMed     Abstract available


  607. RANA T
    Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 21. pii: 6551624. doi: 10.1093.
    PubMed     Abstract available


  608. PETERSON AR, Srinivasan A, Proud D, Jackett L, et al
    Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant.
    Inflamm Bowel Dis. 2022 Mar 15. pii: 6548883. doi: 10.1093.
    PubMed    


  609. CHRISTENSEN B, Prentice RE, Al-Ani AH, Zhang E, et al
    Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement.
    Inflamm Bowel Dis. 2022 Mar 14. pii: 6548311. doi: 10.1093.
    PubMed    


  610. NOGUCHI T, Ando T, Emoto S, Nozawa H, et al
    Artificial Intelligence Program to Predict p53 Mutations in Ulcerative Colitis-Associated Cancer or Dysplasia.
    Inflamm Bowel Dis. 2022 Mar 12. pii: 6547691. doi: 10.1093.
    PubMed     Abstract available


  611. HAASNOOT ML, Mookhoek A, Duijvestein M, D'Haens GRAM, et al
    Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 11. pii: 6547139. doi: 10.1093.
    PubMed     Abstract available


  612. PETER I, Dubinsky M, Xuan S, Chen N, et al
    Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2022 Mar 10. pii: 6546455. doi: 10.1093.
    PubMed    


  613. SHEN J, Liang J, Mao R, Ran Z, et al
    Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542945. doi: 10.1093.
    PubMed     Abstract available


  614. OZSOY M, Stummer N, Zimmermann FA, Feichtinger RG, et al
    Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542923. doi: 10.1093.
    PubMed     Abstract available


  615. SPIERA E, Ganjian DY, Zhang X, Brenner EJ, et al
    Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
    Inflamm Bowel Dis. 2022 Mar 3. pii: 6541762. doi: 10.1093.
    PubMed    


  616. HUDHUD D, Caldera F, Cross RK
    Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
    Inflamm Bowel Dis. 2022;28:492-493.
    PubMed    


  617. COSTANTINO A, Noviello D, Conforti FS, Aloi M, et al
    COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.
    Inflamm Bowel Dis. 2022;28:474-478.
    PubMed    


  618. YU B, Lin C, Yang Y, Yang YF, et al
    Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.
    Inflamm Bowel Dis. 2022;28:e40-e42.
    PubMed    


  619. RAGHAVA RG, Sharma V, Malegaonkar SK, Dhooria S, et al
    Tracheobronchial Crohn's Disease: Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:e33-e35.
    PubMed    


  620. SOFIA C, Adiletta V, Iovene B, Sgalla G, et al
    Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e31-e32.
    PubMed    


  621. DULANEY D, Dave P, Walsh S, Mehandru S, et al
    Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:479-483.
    PubMed    


  622. NICOLETTI F, Hammer L, Furtado S, Mangano K, et al
    Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis.
    Inflamm Bowel Dis. 2022;28:455-465.
    PubMed     Abstract available


  623. BISCAGLIA G, Latiano A, Castellana S, Fontana R, et al
    Germline Alterations in Patients With IBD-associated Colorectal Cancer.
    Inflamm Bowel Dis. 2022;28:447-454.
    PubMed     Abstract available


  624. MARK-CHRISTENSEN A, Lange A, Erichsen R, Froslev T, et al
    Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study.
    Inflamm Bowel Dis. 2022;28:415-422.
    PubMed     Abstract available


  625. BENNETT A, Mamunes A, Kim M, Duley C, et al
    The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:409-414.
    PubMed     Abstract available


  626. SINGH S, Qian AS, Nguyen NH, Ho SKM, et al
    Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016.
    Inflamm Bowel Dis. 2022;28:364-372.
    PubMed     Abstract available


  627. WHITE BA, Ramos GP, Kane S
    The Impact of Alcohol in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:466-473.
    PubMed     Abstract available


  628. YADAV A, Jena A, Arpitha K, Shah J, et al
    Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540315. doi: 10.1093.
    PubMed    


  629. SHEEHAN JL, Jacob J, Berinstein EM, Greene-Higgs L, et al
    The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540317. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  630. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination.
    Inflamm Bowel Dis. 2022 Feb 26. pii: 6537472. doi: 10.1093.
    PubMed    


  631. LAMERS CR, de Roos NM, Heerink HH, van de Worp-Kalter LA, et al
    Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536898. doi: 10.1093.
    PubMed     Abstract available


  632. GROSEN A, Bellaguarda E, Liljeqvist-Soltic I, Mejlby Hansen M, et al
    Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536901. doi: 10.1093.
    PubMed    


  633. QUERA R, Nunez F P, Flores L
    SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534444. doi: 10.1093.
    PubMed    


  634. VALDES DELGADO T, Barranco Castro D, Arguelles Arias F
    Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534443. doi: 10.1093.
    PubMed    


  635. PHILIPPOU A, Birhanu B, Biello A, Keefer L, et al
    A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534445. doi: 10.1093.
    PubMed     Abstract available


  636. KAYAL M, Kohler D, Plietz M, Khaitov S, et al
    Early Pouchitis Is Associated With Crohn's Disease-like Pouch Inflammation in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 21. pii: 6533541. doi: 10.1093.
    PubMed     Abstract available


  637. CAMPBELL JP, Teigen L, Manski S, Blumhof B, et al
    Sarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528831. doi: 10.1093.
    PubMed     Abstract available


  638. BOYD T, Winter RW, Winter HS, Kissous-Hunt M, et al
    Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528828. doi: 10.1093.
    PubMed    


  639. BERBISA MAF, Nielsen KR, Ingham AC, Midjord J, et al
    Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
    Inflamm Bowel Dis. 2022 Feb 9. pii: 6524838. doi: 10.1093.
    PubMed     Abstract available


  640. XIE Y, Li H, Zhou L, Tian F, et al
    A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522051. doi: 10.1093.
    PubMed    


  641. CHONGSRISAWAT V, Suratannon N, Chatchatee P, Ittiwut R, et al
    Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522222. doi: 10.1093.
    PubMed    


  642. THOMAS PWA, den Broeder N, Derikx M, Kievit W, et al
    Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522042. doi: 10.1093.
    PubMed     Abstract available


  643. BOKEMEYER B, Picker N, Wilke T, Rosin L, et al
    Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522041. doi: 10.1093.
    PubMed     Abstract available


  644. MOGHADAM P, Dumas M, Blum L, Gimenez I, et al
    Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn's Disease Under Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022;28:e25-e26.
    PubMed    


  645. JOHNSON S, Ko J, Halabi WJ, Stondell J, et al
    Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e17.
    PubMed    


  646. UENO A, Jijon HB, Peng R, Sparksman S, et al
    Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:246-258.
    PubMed     Abstract available


  647. LEE SD, Singla A, Harper J, Barahimi M, et al
    Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:309-313.
    PubMed     Abstract available


  648. WIEGHARD NEK
    The Difficulty of Distal Crohn's Disease and the Utility of Diverting Stomas.
    Inflamm Bowel Dis. 2022;28:325-326.
    PubMed    


  649. ALRIC H, Amiot A, Kirchgesner J, Treton X, et al
    Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:218-225.
    PubMed     Abstract available


  650. ADLER J, Lee GJ, Singer AAM
    Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working.
    Inflamm Bowel Dis. 2022;28:322-324.
    PubMed    


  651. LIEFFERINCKX C, Bottieau J, Toubeau JF, Thomas D, et al
    Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:208-217.
    PubMed     Abstract available


    January 2022
  652. TANDON P, Lee E, Jogendran R, Kroeker KI, et al
    Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study.
    Inflamm Bowel Dis. 2022 Jan 31. pii: 6517873. doi: 10.1093.
    PubMed     Abstract available


  653. GUZZO GL, Andrews JM, Weyrich LS
    The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517341. doi: 10.1093.
    PubMed     Abstract available


  654. HE ZX, Wang SL, Zhao SB, Li ZS, et al
    An Unusual Case of Hypernatremia in Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517203. doi: 10.1093.
    PubMed    


  655. DA LUZ MOREIRA A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, et al
    Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study.
    Inflamm Bowel Dis. 2022 Jan 28. pii: 6516702. doi: 10.1093.
    PubMed     Abstract available


  656. TARABAR D, El Jurdi K, Traboulsi C, Yvellez O, et al
    A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515101. doi: 10.1093.
    PubMed     Abstract available


  657. SEDANO R, Hogan M, McDonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515239. doi: 10.1093.
    PubMed    


  658. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  659. PETERSON AR, Hilley P, De Cruz P
    Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary?
    Inflamm Bowel Dis. 2022 Jan 19. pii: 6511711. doi: 10.1093.
    PubMed    


  660. COWHERD E, Egberg MD, Kappelman MD, Zhang X, et al
    The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510907. doi: 10.1093.
    PubMed     Abstract available


  661. RUNDE J, Erondu A, Akiyama S, Traboulsi C, et al
    Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510906. doi: 10.1093.
    PubMed     Abstract available


  662. MASSIMINO L, Spano S, Lamparelli LA, Fuggetta D, et al
    Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507842. doi: 10.1093.
    PubMed    


  663. KAPLAN GG, Underwood FE, Coward S, Agrawal M, et al
    The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507839. doi: 10.1093.
    PubMed     Abstract available


  664. LEWIS JD, Cross RK, Long M, Singh S, et al
    High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503739. doi: 10.1093.
    PubMed    


  665. KIM SC
    Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503738. doi: 10.1093.
    PubMed    


  666. CUSHING KC, Du X, Chen Y, Stetson LC, et al
    Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer.
    Inflamm Bowel Dis. 2022 Jan 8. pii: 6501204. doi: 10.1093.
    PubMed     Abstract available


  667. PARK J, Kang SJ, Yoon H, Park J, et al
    Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Inflamm Bowel Dis. 2022 Jan 7. pii: 6500768. doi: 10.1093.
    PubMed     Abstract available


  668. PRENTICE R, Wright EK, Flanagan E, Ross AL, et al
    The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.
    Inflamm Bowel Dis. 2022;28:e13-e16.
    PubMed    


  669. WEI Y, Yang W, Mei Q
    Detection of a Novel Antigen for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e5-e6.
    PubMed    


  670. WEN HZ, He ZH, Li PH, Zhao QF, et al
    Gluteal Sinus Presenting as the Initial Symptom in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e11-e12.
    PubMed    


  671. NAZARI H, Naei VY, Tabasi AH, Badripour A, et al
    Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:133-142.
    PubMed     Abstract available


  672. DALAL RS, Gupta S, Goodrick H, Mitri J, et al
    Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.
    Inflamm Bowel Dis. 2022;28:146-149.
    PubMed    


  673. BOUCHER G, Paradis A, Chabot-Roy G, Coderre L, et al
    Serum Analyte Profiles Associated With Crohn's Disease and Disease Location.
    Inflamm Bowel Dis. 2022;28:9-20.
    PubMed     Abstract available


  674. FAYE AS, Colombel JF
    Aging and IBD: A New Challenge for Clinicians and Researchers.
    Inflamm Bowel Dis. 2022;28:126-132.
    PubMed     Abstract available


  675. JOUSTRA V, Duijvestein M, Mookhoek A, Bemelman W, et al
    Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28:1-8.
    PubMed     Abstract available


  676. TAPETE G, Bertani L, Pieraccini A, Lynch EN, et al
    Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
    Inflamm Bowel Dis. 2022;28:62-69.
    PubMed     Abstract available


  677. BERMEJO F, Jimenez L, Algaba A, Vela M, et al
    Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
    Inflamm Bowel Dis. 2022;28:41-47.
    PubMed     Abstract available


  678. LIU J, Ge X, Ouyang C, Wang D, et al
    Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497520. doi: 10.1093.
    PubMed     Abstract available


  679. YANG H, Qian J
    Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: A questionnaire-based multi-center study.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497521. doi: 10.1093.
    PubMed     Abstract available


  680. ASHTON JJ, Boukas K, Stafford IS, Cheng G, et al
    Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6492639. doi: 10.1093.
    PubMed     Abstract available


  681. LARSEN MD, Norgard BM, Kjeldsen J
    Does Disease Activity After Induction Treatment With Biologics Predict Short-Term Outcome in Crohn's Disease and Ulcerative Colitis?
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6491898. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  682. FANG L, Gao H, Gao X, Wu W, et al
    Risks of Cardiovascular Events in Patients with Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490203. doi: 10.1093.
    PubMed     Abstract available


  683. DULAI PS, Wong ECL, Reinisch W, Colombel JF, et al
    Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490022. doi: 10.1093.
    PubMed     Abstract available


  684. MEISINGER C, Freuer D
    Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Dec 29. pii: 6488545. doi: 10.1093.
    PubMed     Abstract available


  685. SANDBORN WJ, Armuzzi A, Liguori G, Irving PM, et al
    Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 27. pii: 6484790. doi: 10.1093.
    PubMed     Abstract available


  686. SHAH R, Elangovan A, Jordan DW, Katz J, et al
    10-Year Trend of Abdominal Magnetic Resonance Imaging Compared With Abdominal Computed Tomography Scans in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 22. pii: 6479634. doi: 10.1093.
    PubMed     Abstract available


  687. SINGH AK, Sasani A, Dhamor D, Jena A, et al
    Surgical Management of Medical Refractory Acute Severe Ulcerative Colitis in Immune Thrombocytopenic Purpura: Killing Two Birds With One Stone.
    Inflamm Bowel Dis. 2021 Dec 20. pii: 6470737. doi: 10.1093.
    PubMed    


  688. ELIA JR, Beck KR
    The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to "Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review".
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469656. doi: 10.1093.
    PubMed    


  689. SHIMODAIRA Y, Watanabe K, Takahashi S, Koizumi S, et al
    Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2.
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469651. doi: 10.1093.
    PubMed    


  690. HILL JE, Pena-Sanchez JN, Fernando C, Freitas AC, et al
    Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468817. doi: 10.1093.
    PubMed     Abstract available


  691. RAMAN M, Reimer RA, Ghosh S, Vallance J, et al
    The Importance of Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468793. doi: 10.1093.
    PubMed    


  692. BAMIAS G, Pizarro TT, Cominelli F
    Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 14. pii: 6460699. doi: 10.1093.
    PubMed     Abstract available


  693. YANG L, Song X, Chen Y, Li Y, et al
    Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Dec 11. pii: 6459488. doi: 10.1093.
    PubMed     Abstract available


  694. TSE CS, Siegel CA, Weaver SA, Oliver BJ, et al
    Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459204. doi: 10.1093.
    PubMed     Abstract available


  695. JENA A, Sachan A, Singh AK, Sharma V, et al
    Multifocal Pyoderma Gangrenosum at Presentation in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459194. doi: 10.1093.
    PubMed    


  696. WAN Y, Yang L, Jiang S, Qian D, et al
    Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454294. doi: 10.1093.
    PubMed     Abstract available


  697. WEAVER KN, Zhang X, Dai X, Watkins R, et al
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454297. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  698. LEITE-GOMES E, Dias AM, Azevedo CM, Santos-Pereira B, et al
    Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446097. doi: 10.1093.
    PubMed     Abstract available


  699. SUN Y, Geng J, Chen X, Chen H, et al
    Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445975. doi: 10.1093.
    PubMed     Abstract available


  700. CERNA K, Duricova D, Lukas M, Machkova N, et al
    Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445976. doi: 10.1093.
    PubMed     Abstract available


  701. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446094. doi: 10.1093.
    PubMed     Abstract available


  702. BIRDA CL, Agarwal A, Goyal A
    A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438178. doi: 10.1093.
    PubMed    


  703. DESALERMOS A, Pimienta M, Kalligeros M, Shehadeh F, et al
    Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438176. doi: 10.1093.
    PubMed     Abstract available


  704. KJELDSEN S, Nielsen J, Mertz Norgard B, Kjeldsen J, et al
    Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438420. doi: 10.1093.
    PubMed     Abstract available


  705. WESTBERG K, Olen O, Soderling J, Bengtsson J, et al
    Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 18. pii: 6430979. doi: 10.1093.
    PubMed     Abstract available


  706. SACHAN A, Singh AK
    Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.
    Inflamm Bowel Dis. 2021 Nov 15. pii: 6428578. doi: 10.1093.
    PubMed    


  707. PAPALIA I, Tjandra D, Quah S, Tan C, et al
    Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  708. LI Y, Chen J, Bolinger AA, Chen H, et al
    Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  709. HONIG G, Larkin PB, Heller C, Hurtado-Lorenzo A, et al
    Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  710. MOTTA JP, Deraison C, Le Grand S, Le Grand B, et al
    PAR-1 Antagonism to Promote Gut Mucosa Healing in Crohn's Disease Patients: A New Avenue for CVT120165.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  711. YAU YY, Wasinger VC, Hirten RP, Chuang E, et al
    Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  712. BUSQUETS D, Oliver L, Amoedo J, Ramio-Pujol S, et al
    RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  713. TANG J, Huang Z, Guo H, Chao K, et al
    Unexpected Liver Lesions in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e161-e162.
    PubMed    


  714. BORGHINI R, Villanacci V, Oberti A, Caronna R, et al
    Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Inflamm Bowel Dis. 2021;27:e152-e153.
    PubMed    


  715. DAR ANTAKI L, Volkov A, Ben-Horin S
    Cytomegalovirus Limited to the Rectum in an Immunosuppressed IBD Patient.
    Inflamm Bowel Dis. 2021;27:e154-e155.
    PubMed    


  716. ALLEGRETTI JR, Canakis A, McClure E, Marcus J, et al
    Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
    Inflamm Bowel Dis. 2021;27:2031-2033.
    PubMed    


  717. AGUILAR D, Revilla L, Garrido-Trigo A, Panes J, et al
    Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study.
    Inflamm Bowel Dis. 2021;27:1999-2009.
    PubMed     Abstract available


  718. GHAFARI-SARAVI A, Rabizadeh S, Dubovsky A, Miller S, et al
    Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:2034-2037.
    PubMed    


  719. SOMINENI HK, Weitzner JH, Venkateswaran S, Dodd A, et al
    Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1889-1900.
    PubMed     Abstract available


  720. MANZINI R, Schwarzfischer M, Atrott K, Laimbacher A, et al
    Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
    Inflamm Bowel Dis. 2021;27:1986-1998.
    PubMed     Abstract available


  721. WANG MH, Friton JJ, Raffals LE, Leighton JA, et al
    Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2021;27:1968-1974.
    PubMed     Abstract available


  722. FLANAGAN E, Wright EK, Sparrow MP, Moore GT, et al
    A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.
    Inflamm Bowel Dis. 2021;27:1909-1918.
    PubMed     Abstract available


  723. KIM J, Yoon H, Kim N, Lee KM, et al
    Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021;27:1931-1941.
    PubMed     Abstract available


  724. TRIPODI A, Spina L, Pisani LF, Padovan L, et al
    Anti-TNF-alpha Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1901-1908.
    PubMed     Abstract available


  725. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426108. doi: 10.1093.
    PubMed    


  726. HOKAMA A, Fujita J
    Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?"
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426022. doi: 10.1093.
    PubMed    


  727. LUTZ MK, Matthews LA, Tuan WJ, Caldera F, et al
    Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425060. doi: 10.1093.
    PubMed    


  728. JAGT JZ, Struys EA, Ayada I, Bakkali A, et al
    Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425057. doi: 10.1093.
    PubMed     Abstract available


  729. JENA A, Singh AK, Siddharda BV, Panda P, et al
    Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 9. pii: 6425058. doi: 10.1093.
    PubMed    


  730. ZHANG S, Chen F, Wu J, Liu C, et al
    Regional Gray Matter Volume Changes in Brains of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 3. pii: 6420319. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  731. TRIPATHI K, Godoy Brewer G, Thu Nguyen M, Singh Y, et al
    COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412576. doi: 10.1093.
    PubMed     Abstract available


  732. DAI C, Huang YH, Jiang M
    Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412248. doi: 10.1093.
    PubMed    


  733. KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
    The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021;27:1731-1739.
    PubMed     Abstract available


  734. SPENCER EA, Klang E, Dolinger M, Pittman N, et al
    Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:1862-1864.
    PubMed    


  735. CRISPINO F, Brinch D, Carrozza L, Cappello M, et al
    Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Inflamm Bowel Dis. 2021;27:e134-e135.
    PubMed    


  736. DALAL RS, Allegretti JR
    Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:1873-1875.
    PubMed    


  737. CEBALLOS D
    Predictors: How to Approach the Individualization of Treatment.
    Inflamm Bowel Dis. 2021;27:1876-1877.
    PubMed     Abstract available


  738. ARTHUR S, Palaniappan B, Afroz S, Sundaram U, et al
    Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.
    Inflamm Bowel Dis. 2021;27:1804-1812.
    PubMed     Abstract available


  739. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial.
    Inflamm Bowel Dis. 2021;27:1766-1772.
    PubMed     Abstract available


  740. STULMAN MY, Asayag N, Focht G, Brufman I, et al
    Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study.
    Inflamm Bowel Dis. 2021;27:1784-1794.
    PubMed     Abstract available


  741. CALDERA F, Balzora S, Hayney MS, Farraye FA, et al
    Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1703-1705.
    PubMed     Abstract available


  742. KANG MJ, Kim HW, Park SB, Kang DH, et al
    A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothpick Mimicking Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e121-e122.
    PubMed    


  743. VALDES DELGADO T, Arguelles Arias F, Gastearena Idoate MA
    Mixed Adenocarcinoma in a 44-Year-Old Male with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e119-e120.
    PubMed    


  744. PATEL BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al
    Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e124.
    PubMed    


  745. LOU Y, Li Z
    Is It Crohn's Disease?
    Inflamm Bowel Dis. 2021;27:e116-e117.
    PubMed    


  746. ALAYO QA, Khatiwada A, Patel A, Zulfiqar M, et al
    Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1698-1702.
    PubMed    


  747. ADLER J, Eder SJ, Gebremariam A, French KR, et al
    Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CD.
    Inflamm Bowel Dis. 2021;27:1585-1592.
    PubMed     Abstract available


  748. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1626-1633.
    PubMed     Abstract available


  749. KULKARNI C, Murag S, Cholankeril G, Fardeen T, et al
    Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1602-1609.
    PubMed     Abstract available


  750. PATEL DB, van Deen WK, Almario CV, Khalil C, et al
    Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom.
    Inflamm Bowel Dis. 2021;27:1593-1601.
    PubMed     Abstract available


  751. PIPPIS EJ, Yacyshyn BR
    Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD.
    Inflamm Bowel Dis. 2021;27:1674-1683.
    PubMed     Abstract available


  752. REENAERS C, de Roover A, Kohnen L, Nachury M, et al
    Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
    PubMed     Abstract available


  753. ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
    IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
    PubMed     Abstract available


  754. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed     Abstract available


  755. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.
    PubMed    


  756. RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
    Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  757. LEE KE, Lim F, Colombel JF, Hur C, et al
    Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378418. doi: 10.1093.
    PubMed     Abstract available


  758. GU X, Ke X, Shen M, Zhang M, et al
    Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378417. doi: 10.1093.
    PubMed    


  759. MICHEL HK, Boyle B, David J, Donegan A, et al
    The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.
    Inflamm Bowel Dis. 2021 Sep 25. pii: 6375326. doi: 10.1093.
    PubMed     Abstract available


  760. BOOTH A, Ford W, Brennan E, Magwood G, et al
    Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 23. pii: 6374390. doi: 10.1093.
    PubMed     Abstract available


  761. MACISAAC MB, Julsgaard M, Flanagan E, Rowe S, et al
    Anti-TNFalpha Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
    Inflamm Bowel Dis. 2021 Sep 18. pii: 6372251. doi: 10.1093.
    PubMed    


  762. LAWTON RC
    "The Tough Get Going": Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 17. pii: 6371841. doi: 10.1093.
    PubMed    


  763. DAILEY J, Kozhaya L, Dogan M, Hopkins D, et al
    Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 16. pii: 6371006. doi: 10.1093.
    PubMed     Abstract available


  764. OUAHED J
    Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370827. doi: 10.1093.
    PubMed     Abstract available


  765. BADER-MEUNIER B, Martins AL, Charbit-Henrion F, Meinzer U, et al
    Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370829. doi: 10.1093.
    PubMed     Abstract available


  766. VAHIDNEZHAD H, Youssefian L, Anbardar MH, Zeinali S, et al
    Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the alpha6 Integrin Gene (ITGA6).
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370826. doi: 10.1093.
    PubMed    


  767. MISHRA S, Kumar Singh A, Kopp C, Jena A, et al
    Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370835. doi: 10.1093.
    PubMed    


  768. DE VOOGD F, Joshi H, Van Wassenaer E, Bots S, et al
    Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370832. doi: 10.1093.
    PubMed     Abstract available


  769. WU N, Li H, Zhang J, Huang W, et al
    Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?
    Inflamm Bowel Dis. 2021 Sep 4. pii: 6364140. doi: 10.1093.
    PubMed    


  770. HERMAN SM, Zaborniak K, Bernstein CN
    Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362805. doi: 10.1093.
    PubMed     Abstract available


  771. BARNES EL, Nowell WB, Venkatachalam S, Dobes A, et al
    Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362806. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  772. PHILIPPOU A, Sehgal P, Ungaro RC, Wang K, et al
    High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358608. doi: 10.1093.
    PubMed     Abstract available


  773. XERFAN EMS, Andersen ML, Tomimori J, Tufik S, et al
    Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358561. doi: 10.1093.
    PubMed    


  774. RAFFALS LE, Saha S, Bewtra M, Norris C, et al
    The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358125. doi: 10.1093.
    PubMed     Abstract available


  775. MATSUNE Y, Yaguchi K, Saito S, Sakakibara H, et al
    Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum.
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358126. doi: 10.1093.
    PubMed    


  776. HASSAN-ZAHRAEE M, Ye Z, Xi L, Baniecki ML, et al
    Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357022. doi: 10.1093.
    PubMed     Abstract available


  777. MALHI G, Tandon P, Perlmutter JW, Nguyen G, et al
    Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357024. doi: 10.1093.
    PubMed     Abstract available


  778. XU Y, Tian Y, Li F, Wang Y, et al
    Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357021. doi: 10.1093.
    PubMed     Abstract available


  779. SABERZADEH-ARDESTANI B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, et al
    Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Inflamm Bowel Dis. 2021 Aug 21. pii: 6356100. doi: 10.1093.
    PubMed     Abstract available


  780. BARNHOORN MC, Storm BN, de Boer NK, van der Voorn MMPJA, et al
    Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
    Inflamm Bowel Dis. 2021;27:e114-e115.
    PubMed    


  781. KOCHAR B, Kalasapudi L, Ufere NN, Nipp RD, et al
    Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1541-1543.
    PubMed    


  782. WITTE M, Reiner J, Bannert K, Jaster R, et al
    Ileocolonic Healing After Extended Small Bowel Resection in Mice: NOD2 Deficiency Impairs Anastomotic Healing and Postoperative Outcome.
    Inflamm Bowel Dis. 2021;27:1503-1512.
    PubMed     Abstract available


  783. GEISMAN T, Chen L, Gray-Swain MR, Hiatt-Jensen D, et al
    Delivery Outcomes of Pregnant Patients With Inflammatory Bowel Diseases Compared With the General Population and With Women With Other Autoimmune Diseases at a Tertiary Care Center.
    Inflamm Bowel Dis. 2021;27:1418-1426.
    PubMed     Abstract available


  784. YANG Q, Chen L, Feng L, Liu C, et al
    Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 16. pii: 6352953. doi: 10.1093.
    PubMed     Abstract available


  785. DEL SORDO R, Lupinacci G, Tanzi G, Bassotti G, et al
    Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
    Inflamm Bowel Dis. 2021 Aug 10. pii: 6347487. doi: 10.1093.
    PubMed    


    July 2021
  786. UNGARO RC, Agrawal M, Brenner EJ, Zhang X, et al
    New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329562. doi: 10.1093.
    PubMed    


  787. FALSEY A, Jo D, Sirak H, Moya D, et al
    Corticosteroids Can Be Used to Decrease Antidrug Antibodies in Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329558. doi: 10.1093.
    PubMed    


  788. AXELRAD JE, Faye A, Slaughter JC, Harpaz N, et al
    Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329560. doi: 10.1093.
    PubMed     Abstract available


  789. MARKOVIC S, Ivanovski TK, Zogovic B, Kalaba A, et al
    The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.
    Inflamm Bowel Dis. 2021;27:e90.
    PubMed    


  790. WINTER MW, Levy LC
    Maybe Age Isn't Just a Number: Elderly-onset IBD Is a Demographic Deserving of Specific Considerations.
    Inflamm Bowel Dis. 2021;27:1363-1364.
    PubMed    


  791. PRIVITERA G, Pugliese D, Armuzzi A, Guidi L, et al
    Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location.
    Inflamm Bowel Dis. 2021;27:e93-e94.
    PubMed    


  792. NEYAZI M, Bharadwaj SS, Bullers S, Varenyiova Z, et al
    Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1316-1327.
    PubMed     Abstract available


  793. SANTORU ML, Piras C, Murgia F, Leoni VP, et al
    Metabolic Alteration in Plasma and Biopsies From Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1335-1345.
    PubMed     Abstract available


  794. MARRIE RA, Graff LA, Fisk JD, Patten SB, et al
    The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.
    Inflamm Bowel Dis. 2021;27:1285-1293.
    PubMed     Abstract available


  795. ROZICH JJ, Luo J, Dulai PS, Collins AE, et al
    Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.
    Inflamm Bowel Dis. 2021;27:1215-1223.
    PubMed     Abstract available


  796. DALAL RS, Njie C, Marcus J, Gupta S, et al
    Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.
    Inflamm Bowel Dis. 2021;27:1294-1301.
    PubMed     Abstract available


  797. CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
    Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
    PubMed    


  798. SYAL G, Serrano M, Jain A, Cohen BL, et al
    Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
    PubMed     Abstract available


  799. DAI C, Jiang M, Huang YH
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
    PubMed    


  800. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
    PubMed     Abstract available


  801. SHIBUYA T, Nomura O, Nagahara A
    Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
    Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
    PubMed    


  802. OJO BA, VanDussen KL, Rosen MJ
    The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
    PubMed     Abstract available


  803. WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
    Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
    PubMed     Abstract available


  804. KHAN N, Pernes T, Weiss A, Trivedi C, et al
    Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
    PubMed     Abstract available


  805. TSE CS, Singh S, Sandborn WJ
    A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  806. WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
    SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
    PubMed    


  807. CHOSHEN S, Turner D, Pratt LT, Precel R, et al
    Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
    PubMed     Abstract available


  808. TAFT TH, Quinton S, Jedel S, Simons M, et al
    Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
    PubMed     Abstract available


  809. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
    PubMed     Abstract available


  810. MUTLU EA
    IBD Development After Diverticulitis May Hold Clues to IBD Pathogenesis.
    Inflamm Bowel Dis. 2021;27:1172-1173.
    PubMed    


  811. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:e79-e80.
    PubMed    


  812. ALKAISSI LY, Winberg ME, Heil SDS, Haapaniemi S, et al
    Antagonism of Adherent Invasive E. coli LF82 With Human alpha-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1116-1127.
    PubMed     Abstract available


  813. ZHOU LY, Lin SN, Rieder F, Chen MH, et al
    Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.
    Inflamm Bowel Dis. 2021;27:971-982.
    PubMed     Abstract available


  814. MAZZURANA L, Bonfiglio F, Forkel M, D'Amato M, et al
    Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells.
    Inflamm Bowel Dis. 2021;27:1128-1138.
    PubMed     Abstract available


  815. BUISSON A, Mak WY, Andersen MJ, Lei D, et al
    Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
    Inflamm Bowel Dis. 2021;27:1008-1016.
    PubMed     Abstract available


  816. NGUYEN NH, Khera R, Dulai PS, Boland BS, et al
    National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.
    Inflamm Bowel Dis. 2021;27:1068-1078.
    PubMed     Abstract available


  817. RINAWI F, Ricciuto A, Church PC, Frost K, et al
    Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1079-1087.
    PubMed     Abstract available


  818. COLMAN RJ, Tsai YT, Jackson K, Boyle BM, et al
    Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1045-1051.
    PubMed     Abstract available


  819. HASAN B, Yim Y, Ur Rashid M, Khalid RA, et al
    Hyperbaric Oxygen Therapy in Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2021;27:965-970.
    PubMed     Abstract available


  820. NGUYEN NH, Luo J, Ohno-Machado L, Sandborn WJ, et al
    Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort.
    Inflamm Bowel Dis. 2021;27:1026-1034.
    PubMed     Abstract available


  821. KUROWSKI JA, Milinovich A, Ji X, Bauman J, et al
    Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort.
    Inflamm Bowel Dis. 2021;27:1035-1044.
    PubMed     Abstract available


  822. QIN X
    High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
    PubMed    


  823. GALIPEAU HJ, Caminero A, Verdu EF
    Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
    PubMed    


  824. LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
    Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
    PubMed    


  825. GONG L, Xiao J, Yi J, Xiao J, et al
    Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
    PubMed     Abstract available


  826. VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
    Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
    PubMed     Abstract available


  827. DAVID JG, Chute D, Reed B, Saeed S, et al
    Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
    PubMed    


  828. JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
    Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
    PubMed     Abstract available


  829. DANESE S, Peyrin-Biroulet L
    Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
    PubMed     Abstract available


  830. MIKAIL M, Wilson A
    Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
    PubMed    


    May 2021
  831. LUI J, Ramos GP, Codipilly DC, Katzka D, et al
    The Use of Biologics for the Treatment of Esophageal Crohn Disease.
    Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
    PubMed    


  832. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed    


  833. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed     Abstract available


  834. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed    


  835. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed     Abstract available


  836. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed     Abstract available


  837. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed     Abstract available


  838. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed     Abstract available


  839. IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
    Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
    PubMed     Abstract available


  840. SACHAN A, Srivastava S, Shah J, Singh AK, et al
    Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
    Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
    PubMed    


  841. HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
    Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
    PubMed    


  842. HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
    Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
    PubMed     Abstract available


  843. VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
    Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
    PubMed     Abstract available


  844. MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
    The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
    PubMed     Abstract available


  845. CHEAH M, Wilson A, Solh Z, Khanna R, et al
    IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
    PubMed    


  846. VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
    Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
    PubMed    


  847. DOS SANTOS CHM, Koga GA
    Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
    Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
    PubMed    


  848. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
    PubMed    


  849. SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
    PubMed    


  850. DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
    Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
    PubMed     Abstract available


  851. HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
    Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
    PubMed    


  852. FASOULAS K, Stergiou E, Soufleris K
    Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
    PubMed    


  853. SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
    PubMed     Abstract available



  854. Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
    PubMed    



  855. Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
    PubMed    


  856. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed     Abstract available


  857. GRAZIANO F, Buse M, Cassata N, Citrano M, et al
    Cerebral Venous Thrombosis in a Child With Very-Early-Onset IBD.
    Inflamm Bowel Dis. 2021;27:e71-e73.
    PubMed    


  858. SRINIVASAN A, van Langenberg D, De Cruz P
    Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e69.
    PubMed    


  859. AHMED W, Lukin DJ
    Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
    Inflamm Bowel Dis. 2021;27:787-790.
    PubMed    


  860. FIOCCHI C, Iliopoulos D
    IBD Systems Biology Is Here to Stay.
    Inflamm Bowel Dis. 2021;27:760-770.
    PubMed     Abstract available


  861. KUROWSKI JA, Bewtra M, Kodish E, Lashner B, et al
    Reducing the Spread of Internet Misinformation in IBD: Ethics and Responsibility.
    Inflamm Bowel Dis. 2021;27:960-962.
    PubMed    


  862. SUDHAKAR P, Verstockt B, Cremer J, Verstockt S, et al
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
    Inflamm Bowel Dis. 2021;27:870-886.
    PubMed     Abstract available


  863. GUPTA N, Lustig RH, Andrews H, Gokhale R, et al
    Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study).
    Inflamm Bowel Dis. 2021;27:751-759.
    PubMed     Abstract available


  864. WONG ECL, Marshall JK, Reinisch W, Narula N, et al
    Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial.
    Inflamm Bowel Dis. 2021;27:848-854.
    PubMed     Abstract available


  865. LEVINE I, Malik F, Castillo G, Jaros B, et al
    Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:809-815.
    PubMed     Abstract available


  866. VARBOBITIS I, Kokkotis G, Gizis M, Perlepe N, et al
    The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission.
    Inflamm Bowel Dis. 2021;27:826-835.
    PubMed     Abstract available


  867. ATTAUABI M, Zhao M, Bendtsen F, Burisch J, et al
    Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:927-939.
    PubMed     Abstract available


  868. TAXONERA C, Olivares D, Alba C
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
    PubMed    


  869. JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
    Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
    PubMed    


  870. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
    PubMed     Abstract available


  871. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
    PubMed    


  872. CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
    Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
    PubMed     Abstract available


  873. JENA A, Mishra S, Sachan A, Singh H, et al
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
    PubMed    


  874. MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
    Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
    PubMed     Abstract available


  875. ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
    Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
    Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  876. XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
    COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
    PubMed    


  877. HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
    Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
    PubMed     Abstract available


  878. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
    Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
    PubMed    



  879. Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
    PubMed    


  880. ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
    Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Inflamm Bowel Dis. 2021;27:e66.
    PubMed    


  881. FOTEINOGIANNOPOULOU K, Mala A, Koutroubakis IE
    Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case Report.
    Inflamm Bowel Dis. 2021;27:e55-e56.
    PubMed    


  882. MAGEN-RIMON R, Garah J, Rosen I, Shaoul R, et al
    Postsurgical Treatment in Pediatric Patients With Crohn's Disease: Physician Practice.
    Inflamm Bowel Dis. 2021;27:e51-e54.
    PubMed    


  883. OSTERMAN MT, VanDussen KL, Gordon IO, Davis EM, et al
    Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:677-685.
    PubMed     Abstract available


  884. PAULIDES E, Boukema I, van der Woude CJ, de Boer NKH, et al
    The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review.
    Inflamm Bowel Dis. 2021;27:711-724.
    PubMed     Abstract available


  885. CANNATELLI R, Bazarova A, Zardo D, Nardone OM, et al
    Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
    Inflamm Bowel Dis. 2021;27:647-654.
    PubMed     Abstract available


  886. GOREN G, Schwartz D, Friger M, Banai H, et al
    Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
    PubMed     Abstract available


  887. ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
    Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
    PubMed     Abstract available


  888. SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
    Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
    Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  889. HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
    Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
    Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
    PubMed     Abstract available


  890. FANG J, Wang H, Xue Z, Cheng Y, et al
    PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
    PubMed     Abstract available


  891. SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
    Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
    PubMed     Abstract available


  892. KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
    Trajectories of Fatigue in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
    PubMed     Abstract available


  893. STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
    The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
    PubMed     Abstract available


  894. ZHANG T, Xu Y, Yao Y, Jin L, et al
    Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
    PubMed     Abstract available


  895. SANDS BE, Long MD, Reinisch W, Panes J, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
    PubMed     Abstract available


  896. GARRIDO I, Lopes S, Macedo G
    Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
    PubMed     Abstract available


  897. KHORSHID M, AbdAllah M
    Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Inflamm Bowel Dis. 2021;27:e39.
    PubMed    


  898. WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
    Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:590-592.
    PubMed    


  899. AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
    Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Inflamm Bowel Dis. 2021;27:585-589.
    PubMed    


  900. SANTANA GO, de Santana AC, Pfeilsticker VB
    Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
    Inflamm Bowel Dis. 2021;27:e42.
    PubMed    


  901. SEDANO R, Dhaliwal I, Ramsewak D, Jairath V, et al
    Drug-induced Lupus Associated With Vedolizumab in a Patient with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e47-e48.
    PubMed    


  902. FERNANDEZ ALVAREZ P, Maldonado Perez B, Castro Laria L, Arguelles-Arias F, et al
    Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e40-e41.
    PubMed    


  903. ZHOU G, Wu H, Lin J, Lin R, et al
    TRIM21 Is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.
    Inflamm Bowel Dis. 2021;27:458-468.
    PubMed     Abstract available


  904. DALAL RS, Palchaudhuri S, Snider CK, Lewis JD, et al
    Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:500-506.
    PubMed     Abstract available


  905. COLMAN RJ, Portocarrero-Castillo A, Chona D, Hellmann J, et al
    Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:507-515.
    PubMed     Abstract available


  906. PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
    Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
    PubMed     Abstract available


  907. BHAT S, Caldera F, Farraye FA
    Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
    PubMed    


  908. ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
    Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
    PubMed     Abstract available


  909. XIANG BJ, Huang YH, Dai C
    A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
    PubMed    


  910. SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
    The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
    PubMed     Abstract available


  911. ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
    Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
    PubMed     Abstract available


  912. TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
    Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
    PubMed    


    February 2021
  913. VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
    PubMed     Abstract available


  914. NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
    Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
    PubMed    


  915. IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
    SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
    PubMed    


  916. BORGHINI R, Vescovo M, Giordano C, Donato G, et al
    Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
    PubMed    


  917. MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
    Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
    PubMed     Abstract available


  918. CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
    Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
    PubMed     Abstract available


  919. MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
    PubMed     Abstract available


  920. CHUGH R, Proctor DD, Little A, Myung P, et al
    Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e30-e31.
    PubMed    


  921. SOFFER S, Dahan S, Maklakovski M, Dagan A, et al
    A Case of Aseptic Renal Abscesses Associated With IBD.
    Inflamm Bowel Dis. 2021;27:e28-e29.
    PubMed    


  922. LEON G, Hussey S, Walsh PT
    The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution.
    Inflamm Bowel Dis. 2021;27:440-450.
    PubMed     Abstract available


  923. YANG Y, Zhang C, Jing D, He H, et al
    IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:407-417.
    PubMed     Abstract available


  924. STEINER CA, Rodansky ES, Johnson LA, Berinstein JA, et al
    AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
    Inflamm Bowel Dis. 2021;27:303-316.
    PubMed     Abstract available


  925. SCHARRER S, Lissner D, Primas C, Reinisch W, et al
    Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:379-385.
    PubMed     Abstract available


  926. BRENNER EJ, Long MD, Mann CM, Chen W, et al
    Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:344-351.
    PubMed     Abstract available


  927. STONE JK, Shafer LA, Graff LA, Lix L, et al
    Utility of the MARS-5 in Assessing Medication Adherence in IBD.
    Inflamm Bowel Dis. 2021;27:317-324.
    PubMed     Abstract available


  928. TAXONERA C, Olivares D, Alba C
    Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
    PubMed     Abstract available


  929. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
    Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
    PubMed     Abstract available


  930. DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
    PubMed     Abstract available


  931. DALAL RS, Allegretti JR
    Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
    PubMed    


  932. JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
    Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
    Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
    PubMed    


  933. MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
    Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
    PubMed     Abstract available


  934. BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
    Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
    Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
    PubMed     Abstract available


  935. DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
    Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
    PubMed     Abstract available


  936. BALDAN-MARTIN M, Chaparro M, Gisbert JP
    Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
    PubMed     Abstract available


  937. GARG R, Mohammed A, Singh A, Regueiro M, et al
    Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  938. RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
    International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
    PubMed     Abstract available


  939. ROBERTSON AR, Arnott ID
    How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
    PubMed    



  940. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
    PubMed    


  941. SHAH J, Shah A, Hassman L, Gutierrez A, et al
    Ocular Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
    PubMed     Abstract available


  942. CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
    Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
    PubMed    


  943. DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
    Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
    PubMed    


  944. SORRENTINO D, Gray JM
    Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
    PubMed     Abstract available


  945. SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
    Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
    PubMed     Abstract available


  946. SEDANO R, Jairath V
    Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
    PubMed    


  947. SEDANO R, Jairath V
    High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
    PubMed    


  948. BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
    Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:155-161.
    PubMed     Abstract available


  949. HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
    Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Inflamm Bowel Dis. 2021;27:291-294.
    PubMed    


  950. LEE S, Clark-Snustad K
    Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.
    Inflamm Bowel Dis. 2021;27:e20-e22.
    PubMed    


  951. DOS SANTOS CHM, Galindo ACA, da Silva BA, Dantas CR, et al
    Is There Really a Direct Relationship Between IBD and Anxiety/Depression, or Could Any Chronic Disease Have These Manifestations?
    Inflamm Bowel Dis. 2021;27:e18-e19.
    PubMed    


  952. NIGHOT P, Ma T
    Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.
    Inflamm Bowel Dis. 2021;27:283-290.
    PubMed     Abstract available


  953. VAGIANOS K, Shafer LA, Witges K, Targownik LE, et al
    Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2021;27:190-202.
    PubMed     Abstract available


  954. SCHNELL A, Schwarz B, Wahlbuhl M, Allabauer I, et al
    Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy.
    Inflamm Bowel Dis. 2021;27:224-235.
    PubMed     Abstract available


  955. DE CARVALHO LGF, Lima WG, Coelho LGV, Cardoso VN, et al
    Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021;27:169-181.
    PubMed     Abstract available


  956. MACALUSO FS, Fries W, Viola A, Centritto A, et al
    The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.
    Inflamm Bowel Dis. 2021;27:182-189.
    PubMed     Abstract available


  957. BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
    Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
    PubMed     Abstract available


  958. DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
    Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
    PubMed    


  959. TA AD, Ollberding NJ, Karns R, Haberman Y, et al
    Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
    PubMed     Abstract available


  960. ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
    The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
    PubMed    


  961. CHANDE N, Singh S, Narula N, Gordon M, et al
    Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
    PubMed    


  962. WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
    Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
    PubMed     Abstract available


  963. LI N, Zhan S, Tian Z, Liu C, et al
    Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
    PubMed     Abstract available


  964. REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
    Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
    PubMed     Abstract available


  965. FOULON A, Pichois R, Sabbagh C, Fumery M, et al
    Bowel Endometriosis Mimicking Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
    PubMed    


  966. PUGLIESE D, Schepis T, Bove V, Privitera G, et al
    Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
    PubMed    


  967. KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
    Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
    PubMed     Abstract available


  968. HONG S, Zaki TA, Main M, Hine AM, et al
    Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
    PubMed     Abstract available


  969. SCHARRER S, Primas C, Eichinger S, Tonko S, et al
    Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
    PubMed     Abstract available


  970. BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
    Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
    PubMed    


  971. JEON Y, Limketkai BN
    Implications of Dietary Impact on Hepatic Steatosis and IBD.
    Inflamm Bowel Dis. 2021;27:10-11.
    PubMed    


  972. PENRICE DD, Kamboj AK, Simonetto DA
    Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
    Inflamm Bowel Dis. 2021;27:e7-e8.
    PubMed    


  973. REINISCH W, Gecse K, Halfvarson J, Irving PM, et al
    Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:106-122.
    PubMed     Abstract available


  974. RIPOLLES T, Poza J, Suarez Ferrer C, Martinez-Perez MJ, et al
    Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study.
    Inflamm Bowel Dis. 2021;27:145-154.
    PubMed     Abstract available


  975. OLAISEN M, Flatberg A, Granlund AVB, Royset ES, et al
    Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:12-24.
    PubMed     Abstract available


  976. CHICCO F, Magri S, Cingolani A, Paduano D, et al
    Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Inflamm Bowel Dis. 2021;27:1-9.
    PubMed     Abstract available


  977. CALDERA F, Ley D, Hayney MS, Farraye FA, et al
    Optimizing Immunization Strategies in Patients with IBD.
    Inflamm Bowel Dis. 2021;27:123-133.
    PubMed     Abstract available


  978. ARVANITIS M, Hart LC, DeWalt DA, Diaz-Gonzalez de Ferris ME, et al
    Transition Readiness Not Associated With Measures of Health in Youth With IBD.
    Inflamm Bowel Dis. 2021;27:49-57.
    PubMed     Abstract available


  979. SZIGETHY E, Murphy SM, Ehrlich OG, Engel-Nitz NM, et al
    Mental Health Costs of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:40-48.
    PubMed     Abstract available


  980. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2021;27:34-39.
    PubMed     Abstract available


  981. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort.
    Inflamm Bowel Dis. 2021;27:65-73.
    PubMed     Abstract available


    December 2020
  982. HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
    Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
    PubMed     Abstract available


  983. HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
    Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
    Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
    PubMed    


  984. BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
    Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
    PubMed     Abstract available


  985. QIN X
    More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
    PubMed    


  986. CURTIS JR, Regueiro M, Yun H, Su C, et al
    Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
    Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
    PubMed     Abstract available


  987. DWADASI S, Zafer M, Goens D, Paknikar R, et al
    Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
    PubMed     Abstract available


  988. PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
    Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
    PubMed     Abstract available


  989. MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
    The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
    PubMed     Abstract available


  990. LEE C, Hong SN, Kim ER, Chang DK, et al
    Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
    PubMed     Abstract available


  991. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
    PubMed     Abstract available


  992. LEE SH, Walshe M, Oh EH, Hwang SW, et al
    Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
    Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  993. BATTAT R, Lukin D, Scherl EJ, Pola S, et al
    Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
    PubMed     Abstract available


  994. BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
    Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
    PubMed     Abstract available


  995. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
    PubMed     Abstract available


  996. DIMOPOULOS C, Al-Bawardy B
    SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e153-e154.
    PubMed    


  997. UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
    Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
    PubMed     Abstract available


  998. BROMS G, Friedman S, Kim SC, Wood ME, et al
    The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
    PubMed     Abstract available


  999. GEEM D, Kugathasan S
    It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
    PubMed    


  1000. SEDANO R, Jairath V
    Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
    PubMed    


  1001. ATTAUABI M, Burisch J, Seidelin JB
    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
    PubMed    


  1002. GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
    Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
    Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
    PubMed     Abstract available


  1003. BRETON J, Witmer CM, Zhang Y, Downing M, et al
    Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
    PubMed     Abstract available


  1004. SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
    Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
    PubMed     Abstract available


  1005. RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
    The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
    PubMed     Abstract available


  1006. SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
    Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
    PubMed     Abstract available


  1007. CORDES F, Lenker E, Weinhage T, Spille LJ, et al
    Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
    PubMed     Abstract available


  1008. SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
    PubMed    


  1009. HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
    Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
    PubMed     Abstract available


  1010. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
    PubMed     Abstract available


  1011. BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
    Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
    PubMed     Abstract available


  1012. BLOOMFELD RS, Bickston SJ
    Financial Toxicity in People With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  1013. DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
    Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
    PubMed     Abstract available


  1014. RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
    The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
    PubMed     Abstract available


  1015. BEHZAD C, Taheri H, Kashifard M
    Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e140.
    PubMed    


  1016. HORRIGAN JM, Siegel CA, Tadros M
    Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e137.
    PubMed    


  1017. ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
    Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:1771-1778.
    PubMed    


  1018. MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
    Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
    PubMed     Abstract available


  1019. FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
    Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
    PubMed     Abstract available


  1020. RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
    Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
    Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
    PubMed     Abstract available


  1021. KE J, He R, Hou X
    Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
    PubMed    


  1022. ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
    Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
    PubMed     Abstract available


  1023. VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
    Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
    PubMed     Abstract available


  1024. DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
    Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
    PubMed    


  1025. CHEN G, Lissoos T, Dieyi C, Null KD, et al
    Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
    PubMed     Abstract available


  1026. DOS SANTOS CHM, Koga GA
    The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
    PubMed    


  1027. TRINDADE IA, Ferreira NB
    COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
    PubMed     Abstract available


  1028. MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
    Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
    PubMed    


  1029. FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
    Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
    Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
    PubMed    


  1030. FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
    Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  1031. YU Q
    Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
    PubMed     Abstract available


  1032. PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
    Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
    PubMed     Abstract available


  1033. KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
    Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
    PubMed     Abstract available


  1034. SINH P, Cross R
    Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
    PubMed     Abstract available


  1035. NAVANEETHAN U, LehnerNoguera V
    Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Inflamm Bowel Dis. 2020;26:e124.
    PubMed    


    August 2020
  1036. ZHANG Q, Chen D, Yang Y
    Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2020;26:e101.
    PubMed    


    July 2020
  1037. GOYAL A
    Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
    Inflamm Bowel Dis. 2020;26:1222-1224.
    PubMed    


    June 2020
  1038. FLESHNER P
    Editorial on Hirten et al.
    Inflamm Bowel Dis. 2020;26:1059.
    PubMed    


  1039. LIGHTNER AL
    Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
    Inflamm Bowel Dis. 2020;26:1087-1088.
    PubMed    


    May 2020
  1040. XU F, Chen D, Yang Y
    Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e47.
    PubMed    


  1041. MCHENRY S, Ciorba MA, Deepak P
    Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e46.
    PubMed    


  1042. DAVIS BC
    Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Inflamm Bowel Dis. 2020;26:960.
    PubMed    


  1043. ZUNDLER S
    Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
    Inflamm Bowel Dis. 2020;26:907-908.
    PubMed     Abstract available


  1044. LUKIN DJ
    Predictors of Perianal Fistula Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:932-933.
    PubMed    


    April 2020
  1045. KOUTROUMPAKIS F, Lodhi M, Ahsan M, Ramos Rivers C, et al
    The Impact of Cholecystectomy on Long-Term Disease Outcomes and Quality of Life in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822893. doi: 10.1093.
    PubMed     Abstract available


  1046. TURNER D
    Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
    Inflamm Bowel Dis. 2020;26:e42.
    PubMed    


  1047. LIN S, Lin X, Li X, Chen M, et al
    Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
    Inflamm Bowel Dis. 2020;26:743-745.
    PubMed    


    March 2020
  1048. LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
    Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
    Inflamm Bowel Dis. 2020;26:510-514.
    PubMed     Abstract available


  1049. BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
    Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
    Inflamm Bowel Dis. 2020;26:628-634.
    PubMed     Abstract available


    February 2020
  1050. GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
    Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
    Inflamm Bowel Dis. 2020;26:e17-e18.
    PubMed    


  1051. JUKEMA JB, Brandse JF, de Boer NKH
    Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Inflamm Bowel Dis. 2020;26:e19.
    PubMed    


  1052. SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
    The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Inflamm Bowel Dis. 2020;26:407-422.
    PubMed     Abstract available


  1053. JUN X, Ning C, Yang S, Zhe W, et al
    Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Inflamm Bowel Dis. 2020;26:380-390.
    PubMed     Abstract available


  1054. CORDES F, Lenker E, Spille LJ, Weinhage T, et al
    Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Inflamm Bowel Dis. 2020;26:391-406.
    PubMed     Abstract available


  1055. VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
    The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
    Inflamm Bowel Dis. 2020;26:369-379.
    PubMed     Abstract available


  1056. GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
    Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
    Inflamm Bowel Dis. 2020;26:423-428.
    PubMed     Abstract available


    January 2020
  1057. KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
    Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Inflamm Bowel Dis. 2020;26:216-228.
    PubMed     Abstract available


  1058. WANG X, Bootsma H, Kroese F, Dijkstra G, et al
    Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
    Inflamm Bowel Dis. 2020;26:e8-e9.
    PubMed    


  1059. LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
    Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:304-313.
    PubMed     Abstract available


  1060. EGBERG MD, Galanko JA, Kappelman MD
    Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
    Inflamm Bowel Dis. 2020;26:254-260.
    PubMed     Abstract available


  1061. LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
    Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Inflamm Bowel Dis. 2020;26:321-330.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.